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Abstract
OBJECTIVE: This study aimed to investigate whether methylphenidate medication
was effective in improving response inhibition in children with ADHD, using a
newly developed measure of response inhibition - the Animal Stroop Task. In
addition, the study examined children's own attributions for their level of response
inhibition across a variety of variables, including medication status.
METHOD: A between subjects design was used to compare a group of children
with ADHD and a control group of normally developing children on measures of
response inhibition, locus of control and behavioural attributions. Participants with
ADHD were tested in two separate conditions - unmedicated and medicated.
Additional within subjects comparisons were used to compare response inhibition
and behavioural attributions across the two conditions.
RESULTS: There was no significant difference between the inhibitory control of
children with ADHD and those of children in the control group but children with
ADHD did show a significant improvement in inhibitory control following
methylphenidate medication. There was no difference between the Locus of Control
scores of children with and without ADHD and no significant relationship between
locus of control and inhibitory control in any condition. Children with and without
ADHD did not differ in the degree to which they attributed their performance to
external factors and these attributions did not vary as a function of medication status.
CONCLUSION: The current findings contradict previous evidence documenting
deficits in the inhibitory control of children with ADHD, and challenge the well-
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established theory that poor response inhibition is the cardinal feature of ADHD.
Reports of methylphenidate improving the functioning of children with ADHD are
supported but there is no evidence to suggest that children with ADHD are any more
likely to make external attributions for their behaviour, irrespective of medication





Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder with
the cardinal features of developmentally inappropriate levels of sustained attention,
distractibility, hyperactivity, and impulse control (Barkley, 2000). It arises early in
childhood, typically between 3 and 7 years of age and, being relatively stable,
persists through adolescence and into adulthood in 30-70% of cases (Weiss &
Murray, 2003). Increasing numbers of children are being diagnosed with ADHD and
current estimates indicate that 3-5% of the American population has ADHD
(Goldman et ah, 1998) with similar proportions within the UK population of
primary-school aged children (Taylor, 1999b). ADHD is known to have
neuropsychological consequences that are evident from psychological tests and
measures of school failure (Seidman et ah, 1997). As such, the disorder is associated
with both concurrent and long-term impairments in academic and social functioning
(Johnston, 1998). Comorbidity is common in ADHD and a significant proportion of
those diagnosed go on to develop delinquent activities and antisocial personalities
(Barkley, 2000). Consequently, the burden of ADHD to affected individuals, to
their families, and to society is considerable.
Moving away from the traditional, established view of a triad of impairment
(inattention, hyperactivity and impulsivity), neuropsychological models now
consider children with ADHD to have difficulties in terms of cognitive attention and
10
executive functioning deficits (e.g. Lawrence et al., 2002). More specifically,
researchers have emphasized poor behavioural/response inhibition as the central
impairment of the disorder (Barkley, 1990). Such contentions are supported by the
findings of research demonstrating children with ADHD are impaired on
neuropsychological tests of response inhibition (e.g. Shue & Douglas, 1992;
Pennington & Ozonoff, 1996).
While the behavioural difficulties associated with ADHD are often managed with
psychotherapeutic approaches, there is an absence of positive outcome studies
(Brown and Levers, 1999). Instead, a large-scale multi-modal treatment study of
children with ADHD demonstrated that the most effective treatment for ADHD was
closely managed pharmacotherapy (MTA Cooperative Group, 1999). Despite
several challenges to these findings (e.g. Owens & Hoza, 2003), well-titrated medical
treatment for ADHD remains the treatment of choice (Hood et al., 2005).
Several authors (e.g. Bugental et al., 1977) have expressed concern that successful
treatment with medication may have an adverse effect on children's self-perceptions
and argue that it may lead them to attribute their behaviour to external factors (e.g.
the drug) while viewing their own efforts/abilities as having a relatively minor role.
It has been speculated that this may result in children becoming reliant on drugs to
focus their attention and effort, meaning that when medication is discontinued, they
are left feeling that they have no way of controlling their behaviour (Rosen et al.,
1985). Existing evidence is varied. While some case studies (e.g. Rosen et al., 1985)
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and indirect evidence suggests that medication does have these negative effects,
others have found little evidence to support the notion that medication produces
predominantly external, medication-related explanations for performance (e.g.
Milich et ah, 1989). While most studies examining the attributional responses of
children with ADHD measure task performance using tests of sustained attention
and/or assessing their social/behavioural conduct, little research has looked at the
direct effects ofmedication on response inhibition.
The aim of this study is to examine whether methylphenidate is effective in
improving response inhibition in children with ADHD, using a using a newly
developed measure of response inhibition - the Animal Stroop Task (Wright et al.,
2003). In addition, the study intends to examine children's own attributions for their
level of response inhibition across a variety of variables, including medication status.
Terminology
In this study, the term Attention Deficit Hyperactivity Disorder (ADHD) will be used
to describe the syndrome of inattention, overactivity and inattention. While there are
different terms available depending on the diagnostic system utilised, these systems
ultimately describe very similar disorders. For the purpose of this study, then, the
terminology used by the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) (American Psychological Association, 1994) will be
adopted.
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'Response inhibition' and 'inhibitory control' are both terms used to denote the same
facility and are therefore used interchangeably throughout this research.
Literature Search
Electronic literature searches were undertaken using OVID and Cochrane based
databases, in addition to a Google Search Engine. The following key words were
used in combination as well as individually - Attention Deficit Hyperactivity
Disorder / ADHD / Hyperactivity / Children / Executive Function / Response
Inhibition / Inhibition / Impulsivity / Stroop / Methylphenidate / Stimulant
Medication / Pharmacological / Behavioural Intervention / Psychosocial Intervention
/ Locus of Control / Attributions / Self-perceptions. Citations in relevant articles
were also reviewed.
The introduction will begin with an examination of the definition of ADHD. This
will be followed by an overview of the current procedure for diagnosing ADHD and
the aetiology of the disorder. The next section will focus on the role of Executive
Functioning in ADHD, moving on to look more specifically at response inhibition
and neuropsychological theories of ADHD, before examining the current methods of
treatment for ADHD. Finally, the introduction will end with a discussion of
behavioural attributions and locus of control in children with ADHD.
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1.2. Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder
characterised by developmentally inappropriate levels of four core features -
sustained attention, distractibility, hyperactivity, and impulse control (Barkley,
1997). It emerges early in childhood, usually between the ages of 3 and 7 years old
and, being relatively stable, persists through adolescence and into adulthood in 30-
70% of cases (Weiss & Murray, 2003). The disorder is more commonly found in
boys, outnumbering the incidence of ADHD in girls by between 4:1 (Gaub &
Carlson, 1997) and 3:1 (Barkley, 1997). ADHD encompasses three subtypes -
inattentive, hyperactive-impulsive, and combined ADHD (Rappley, 2005).
Increasing numbers of children are being diagnosed with the condition and it is now
one of the most commonly diagnosed behavioural disorders in children and
adolescents (SIGN, 2001). While prevalence rates vary depending on the population
sampled, as well as the method of assessment and diagnostic criteria used, most
estimates sit between 5 and 10% (Taylor et ah, 1991). Current estimates indicate that
3-5% of the American population has ADHD (Goldman et ah, 1998) with similar
proportions within the UK population of primary-school aged children (Taylor,
1999b). ADHD is known to have neuropsychological consequences that are evident
from psychological tests (Seidman et ah, 1997). As such, the disorder is associated
with both concurrent and long-term impairments in academic and social functioning
(Johnston, 1998) which can lead to frustration, emotional lability and low self-esteem
amongst those diagnosed (Moser & Bober, 2002).
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Comorbidity is common in ADHD. Sixty seven percent of children diagnosed with
ADHD present with more than one psychiatric diagnosis, of which oppositional
defiant disorder (33%), conduct disorders (25-35%), anxiety disorders (<25%) and
learning disability (12%) are the most frequently cited (Moser & Bober, 2002). Co-
morbid reading disorders are also particularly common in children with ADHD, with
such difficulties occurring in approximately one-third of clinic referred children
(August & Garfinkel, 1990). Although the rate of ADHD diminishes in adolescence
(Cohen et al., 1993), the disorder does persist in a high proportion of individuals
(Weiss & Murray, 2003). However, the resources available to such individuals are
limited and a significant proportion go onto develop delinquent activities and
antisocial personalities (Barkley, 2000). As well as the individuals themselves being
affected, parents of children with ADHD experience higher levels of stress and
depression and sibling relationships are also more troublesome (Hankin, 2001).
Compared with the general population, patients with ADHD are more likely to
require access to mental health services and to generate substantial costs in terms of
resources, time and money across home, school and community settings (DeNisco et
al., 2005). Consequently, the burden of ADHD to affected individuals, to their
families, and to society is considerable (Barkley, 2000).
1.3. How is ADHD Diagnosed?
The initial presentation of ADHD will usually be to general practitioners or other
primary care, education or social work professionals. While all of these professions
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may be involved in a preliminary assessment, it is recommended that the child is also
referred for assessment by a child and adolescent psychiatrist or paediatrician
specialising in this field (SIGN, 2001).
Although there are now a number of well-tested diagnostic interview methods
available for the reliable assessment of ADHD, there is no independent, valid test for
ADHD (NIH Consensus Statement, 1998). It has been suggested, however, that the
critical components of any ADHD assessment should include a thorough history of
the patient and their family (involving detailed patient and carer interviews),
behavioural checklists and reports from both parents and teachers, a brief mental
status examination, as well as a full physical examination and laboratory testing of
various bodily functions - in order to exclude any underlying medical conditions
and/or to identify co-morbid disorders (DeNisco et al., 2005).
The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-
IV) (American Psychological Association, 1994), and the International Classification
of Diseases, Tenth Edition (ICD-10) (World Health Organisation, 1992) currently
provide two of the most widely used criterion to assist diagnosis. While many of the
various systems use different terms to describe the disorder (e.g. Attention Deficit
Hyperactivity Disorder; Hyperkinetic Disorder; Attention Problems Syndrome), most
systems ultimately describe very similar syndromes, encompassing features of
inattention, overactivity and impulsivity.
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The diagnostic criterion outlined in the DSM-IV and ICD-10 is generally very
similar, with the few differences that do exist relating to symptom severity and
pervasiveness. Diagnosis of ADHD is usually not certain before the age of four
years old, due to the fact that many of the identified behaviours may be typical of
normal development (DeNisco et ah, 2005). Nonetheless, some symptoms of
hyperactivity, impulsivity or inattentiveness must be evident before the age of 7
years and have persisted for over 6 months (DSM-IV, 1994). These criteria differ
slightly within the ICD-10 which stipulates an onset of before six years of age with
symptoms being of 'long duration' (ICD-10, 1992). Appendix 7.1 contains the
diagnostic criteria for attention and hyperactivity syndromes as outlined in the DSM-
IV, ICD-10.
Both manuals specify that in order for a diagnosis to be reached, symptoms must be
present in at least two different settings, such as home and school. Indeed, within the
United Kingdom, the diagnosis of ADHD tends to be more narrowly defined, with
much of the emphasis being placed on this required stability of problems across
home and school environments (Carr, 1999). In contrast, this cross-situation
consistency tends not to comprise a core diagnostic criterion in the US (Hinshaw,
1994).
Furthermore, in order to reach a diagnosis of ADHD, symptoms must have caused
significant functional impairment and should not be better accounted for by other
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mental disorders (e.g. pervasive developmental disorder, depression or anxiety,
schizophrenia, other psychotic disorders).
The DSM-IV goes on to divide ADHD into three distinct subtypes - Inattentive;
Hyperactive-Impulsive; Combined. The presence of six or more symptoms of
inattention (e.g. difficulty sustaining attention, inability to listen when spoken to,
easily distractible) can result in the diagnosis of ADHD, predominantly inattentive
subtype (AD/HDin). On the other hand, a patient who displays six or more
symptoms of hyperactive or impulsive behaviour (e.g. fidgeting, excessive talking,
excessive running/climbing in inappropriate situations) would tend to be diagnosed
with ADHD, predominantly hyperactive-impulsive type (AD/HDhyp). A diagnosis
of ADHD combined type (ADHDcom) is given when the symptoms are evenly
divided (i.e. six or more symptoms in each category).
The ICD-10 favours the term 'hyperkinetic disorder', arguing that there is
insufficient knowledge about the psychological processes to warrant identifying the
disorder as 'attention deficit'. ICD-10 tends to specify two different sub-types,
depending on whether additional features of conduct disorder are present -
'hyperkinetic disorder with disturbance of activity and attention' when antisocial
features of conduct disorder are absent; 'hyperkinetic conduct disorder' when criteria
for both conduct disorder and hyperkinetic disorder are met.
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In line with DSM-IV and ICD-10, there are numerous checklists and rating scales
which aim to aid the diagnostic process. For instance, both the Conners ADHD
index (Conners, 1996) and Achenbach's Child Behaviour Checklist System
(Achenbach, 1991) utilise a parent and teacher report form containing similar sets of
core features, with a number of additional items being specific to either the home or
school contexts. Several similar rating scales are available, most of which
discriminate adequately between children with and without ADHD (Guerva & Stein,
2001). In a recent review examining various diagnostic procedures (Green et ah,
1999), the Conners ADHD index and DSM-IV-based symptoms scales (teacher and
parent versions) performed best out of seven rating scales and four checklists.
Barkley's school situation questionnaire (Barkley& Edelbrock, 1987) performed
most poorly. The authors note, however, that having used single studies to calculate
effect sizes for each checklist, reliability may be limited and results should therefore
be interpreted with caution (Green et ah, 1999).
1.4. The Aetiology of ADHD
While ADHD is recognised as a medical diagnosis, as we can see from the above
diagnostic procedures, it does not refer to a set of biological symptoms with a distinct
pathology. Instead, like the majority of psychiatric disorders, ADHD is a term used
to describe a particular cluster of behaviours (Brown, 2004).
As such it is perhaps not surprising that, over the years, the classification of what
constitutes ADHD has changed dramatically. Descriptions of ADHD date back to
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the beginning of last century when Still (1902) identified a group of children he
classed as having difficulties in 'moral control'. He believed the central deficit in
this disorder was volitional inhibition. Subsequent descriptions moved onto identify
hyperactivity, inattention and impulsivity as key to the disorder (Laufer & Denhoff,
1957), with a later emphasis being placed on self-regulation and inhibition as the
cardinal features (Douglas, 1983; Barkley, 1997). Carr (1999) outlines the clinical
features of ADHD as being within the domains of cognition, affect, behaviour,
physical health and interpersonal adjustment. Within the domain of cognition,
features include short attention span, distractibility, and inability to anticipate
behavioural consequences which is usually accompanied by an inability to internalise
rules of social conduct. With regard to affect, individuals usually display reduced
levels of impulse control and tolerance for frustration. Low mood is common, but
often accompanied with periods of increased excitability. In terms of behaviour,
children with ADHD are typically very active and aggression, anti-social behaviour
and increased levels of risk-taking behaviour are also common. Physical health
problems may include injuries or medical complications which are often associated
with antisocial behaviour such as fighting and/or drug abuse.
While the behaviours associated with ADHD are relatively easy to observe and
measure, it has proven considerably more difficult to identify particular cognitive
delays, deficits or dysfunctions that might underpin the disorder (Warner-Rogers,
2002). Indeed, the origins of ADHD have been, and continue to be, much debated
(see Barkley, 1990 or Tannock, 1998 for a review), with several possible aetiologies
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being put forward - including both environmental and central nervous system
disturbances (e.g. Rappley, 2005), as well as more genetic based explanations (e.g.
Moser & Bober, 2002).
It is now generally recognised that the development of ADHD is likely to be multi¬
factorial (Taylor, 1999a), and, involving a combination of interacting genetic,
biological and environmental factors, it has been referred to as
"a paradigm for a true biopsycliosocial disorder" (Tannock, 1998, pg. 65).
1.4.1. Genetics of ADHD
There is currently little doubt that genetic factors play a substantial role in the
development of ADHD (Stevenson, 2005). Initially, studies focused on
demonstrating the highly heritable nature of ADHD. For example, children with
ADHD are more likely to have a parent with the disorder (Smalley et ah, 2000), and
figures show a higher concordance rate of pervasive hyperactivity among
monozygotic twins (51%) in comparison to dizygotic twins (30%) (Goodman &
Stevenson, 1989 a, b).
From here, studies moved their focus to identifying which particular genes might be
involved. While several potential genetic mechanisms continue to be explored,
research has primarily focused on the genes involved in dopaminergic transmission,
with particular attention having been given to exploring variations in the dopamine 4
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receptor gene (LaHoste et al., 1996). More specifically, current consensus suggests
that inherited variants of the genes that function to modulate dopaminergic
neurotransmission may play a role in changing the structure and function of
particular brain regions, subsequently leading to abnormalities in psychological
functioning, such as difficulties inhibiting inappropriate responses (Taylor, 1999a).
These contentions are backed up by findings that dopaminergic drugs
(methylphenidate) are clinically effective in reducing the core symptoms of ADHD,
while imaging studies utilising Positron Emission Tomography (PET) and Magnetic
Resonance Imaging (MRI) techniques have highlighted an association between
ADHD and the frontostriatal circuitry - an area rich in dopaminergic activity (Daley,
2006). Nonetheless, genetic studies continue to explore new avenues, such as the
role played by serotonin transporters (Manor et al., 2001), and now extend to
examining the possibility that different genetic mechanisms may be involved
dependent on the specific subtype ofADHD being investigated (Daley, 2006).
However, genetic studies clearly cannot provide a full explanation of the
development of ADHD. As yet, no single or multiple gene association has been
identified (Rubia & Smith, 2001). Furthermore, although there is substantial
evidence for a familial transmission in ADHD, this link cannot exclude an
explanation of a purely environmental causation. Family and twin studies are
compounded by the increased incidence of shared environmental experience, while
adoption studies are limited and subject to methodological limitations (e.g. the
selective placement of adoptees, the lack of direct comparison between the biological
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and adoptive relatives of the same adoptee, as well as failure to perform blind
evaluations of their participants (Joseph, 2000)). As such, the potential role of
genetic factors in ADHD is an issue that remains to be confirmed.
1.4.2. Brain Structure in ADHD
There is now an abundance of recent research examining the anatomical structure of
the brains of children with ADHD. Functional and structural neuroimaging studies
suggest that there are abnormalities within the brain circuits linking the prefrontal
cortex, striatum and cerebellum (Castellanos & Acostas, 2002) and, in comparison to
controls, children with ADHD tend to have slightly lower total brain volumes
(Castellanos et al., 1996). However, the results remain conflicting with regard to the
exact pathology of the disorder (Eliez & Reiss, 2000) and several authors (e.g. Daley,
2006, Rubia & Smith, 2001) have highlighted the need for further research in this
area. Notably, Rubia & Smith (2001) also caution that, given recent findings that
function, behaviour and environmental stress factors have been shown to alter brain
structure and function, neurobiological abnormalities can no longer be seen as the
cause of the disorder.
1.4.3. Environmental Influences on ADHD
Warner-Rogers (2002) highlights that genetic research has also revealed a number of
non-genetic factors which can impact on the developmental course of ADHD. For
instance, maternal smoking and pre-eclamptic toxaemia have been associated with
hyperactivity (Taylor, 1999a), as has prenatal exposure to alcohol (Taylor et al.
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1991). Other risk factors for the development of ADHD include very low birth
weight, severe anoxia, and early lead poisoning (Taylor, 1999a).
While problems in family functioning may not give rise to ADHD symptoms per se,
it can affect the development of such problems (Taylor, 1999a). Indeed, the
interaction between genetic and environmental factors is highlighted by contentions
that children with a genetic predisposition will present with the disorder when placed
in the right environment, typically one of chaotic parenting (Johnston & Mash,
2001). However, it should be noted that whilst studies have demonstrated less
optimal parenting styles in parents of children with ADHD (e.g. Gardner, 1994), the
relationship between ADHD and parenting may result from a combined force of
negative aspects of the child influencing the parents behaviour, as well as negative
features of the parents affecting the child's behaviour (Daley, 2006). In addition,
when we consider the aforementioned familial link between children with ADHD
having a parent with ADHD (Smalley et ah, 2000), we can appreciate how, in some
families, parents' own symptoms may interfere with any attempt to implement a
suitably consistent approach to parenting.
Diet is another factor which often comes under any discussion around the
environmental variables influencing ADHD. However, while symptoms of ADHD
have been associated with food additives, refined sugars and fatty acid deficiencies,
the validity of such studies is troubled by numerous methodological problems and
small sample sizes (Schnoll et ah, 2003). More recent studies have failed to make
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links between hyperactivity and food additives (e.g. Bateman et al., 2004) and
current guidelines on ADHD in Children and Young People stipulate that there is no
established evidence base allowing specific dietary therapies to be recommended
(SIGN, 2001).
Overall then, it appears that the developmental course of ADHD may be subject to a
number of interacting genetic, biological and environmental factors. However,
despite various associations having been made, results are often conflicting and, as
yet, a fully-comprehensive aetiological explanation for the disorder remains to be
established. As such, this lack of clarity, serves to add to the controversy
surrounding the disorder as a whole.
Barkley (1997) highlights that, historically, research has been based on exploratory
and descriptive methods, and, as such, the widely accepted view of ADHD (as
stipulated by DSM-IV) has primarily focused on behavioural deficits - i.e.
inattention, hyperactivity and impulsivity. He argues that these features are unable to
adequately account for the full range of cognitive and behavioural deficits typical of
ADHD and draws attention to a number of more theory-driven neuropsychological
explanations which aim to give a more comprehensive explanation. Thus, moving
away from the traditional, established view of a triad of impairment (inattention,
hyperactivity and impulsivity), the more recent neuropsychological views tend to
regard children with ADHD as having difficulties within the realms of self-regulation
and executive functioning (e.g. Lawrence et al., 2002; Barkley, 1997).
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1.5. Executive Functioning in ADHD
'Executive functioning' is a term used to describe the mental activities that enable
self-control and goal-directed behaviour. It is defined as:
"those capacities that enable a person to engage successfully in independent,
purposive, self-serving behaviour" (Lezak, 1995, pg. 42).
Such abilities are thought to be regulated by the prefrontal cortex region of the brain,
including its extended networks (Lezak, 1995). The term 'executive functioning' is
regarded as encompassing several different processes, such as working memory, self-
regulation of emotion, motivation and response inhibition (Barkley, 1997) and has
been branded as,
"the seat ofsocial intelligence" (Barkley, 2000, pg. 1068).
Executive impairment typically results in reduced capacity for self control and/or
self-direction, heightened irritability and excitability, impulsivity, erratic
carelessness, rigidity and difficulty in making shifts in attention and on-going
behaviour (Lezak, 1995). Thus, in many ways the clinical description of executive
impairment resembles the aforementioned behavioural descriptions ofADHD.
Indeed, due to the similarity in the presentation of individuals with ADHD and
patients who have suffered frontal lesions in the brain - the latter also resulting in
hyperactive, distractible and/or impulsive behaviour (Fuster 1989; Stuss & Benson,
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1986) - a number of researchers have implicated frontal lobe dysfunction and
executive impairment in ADHD (e.g. Rosenthal & Allen, 1978). Accordingly,
neurological studies involving patients with ADHD have found evidence of
neuroanatomical differences suggestive of anterior dysfunction (Hynd et al., 1993).
Furthermore, instead of displaying the normal right-dominant frontal asymmetry, the
brains of children with ADHD are typified by a smaller right frontal width, resulting
in symmetrical frontal lobes (Hynd et al., 1990).
In line with these contentions, studies utilising tests of executive functioning have
found that, when compared with matched controls, children with ADHD show
deficits in a number of executive functioning tasks. For instance, Gorenstein et al.
(1989) found deficits in attentional set shifting (Gorenstein et al., 1989), as well as
deficits in response inhibition (Gorenstein et al., 1989; Booth et al., 2005), time
slowness (Gorenstein et al., 1989) and planning ability (Weyandt & Willis, 1994).
In a recent review by Pennington and Ozonoff (1996), 15 out of 18 studies found a
significant difference between ADHD participants and controls on at least one
measure of executive function. Results yielded a number of tests which were
particularly sensitive to ADHD, namely the Tower of Hanoi (assessing planning
ability), Stroop (task of inhibition), Matching Figures Test (a measure of impulsivity)
and the Trail Making Test, Part B (assessing flexible set-shifting). Consistent group
differences were also found on measures of motor control and working memory
(Pennington & Ozonoff, 1996).
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Others, however, have failed to replicate these findings. For instance, using
comparable measures of executive functioning, Grodinsky & Diamond (1992) found
that participants with ADHD showed no significant impairments in attentional set-
shifting, response inhibition or time slowness. More recent studies have also failed
to replicate findings of deficits on motor planning and verbal fluency (Speltz et al.,
1999).
It has been suggested that the equivocal nature of findings is perhaps due to the
possibility that, having been validated on adults, many tests of executive function
may have limited validity for use with children (Kempton et al., 1999). Nonetheless,
considering the lack of clarity of results, it is perhaps not surprising that there is still
debate surrounding the exact nature of these deficits (Pennington & Ozonoff, 1996)
and much of the current research now focuses on identifying those executive
functioning processes which are principal in explaining ADHD.
1.6. Response Inhibition in ADHD/Neuropsychological Theories of ADHD
Extending this work on executive functioning, Barkley (1997) argues that the central
impairment in ADHD is a pervasive deficit in response inhibition - i.e. the ability to
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inhibit a prepotent response1, interrupt an ongoing sequence and resist interference
(Barkley, 1997). Response inhibition is defined more simply as,
"the ability to stop (suddenly and completely) a planned or ongoing thought and
action" (Williams et ah, 1999, pg. 205).
This level of control is crucial in numerous everyday situations where changes to
one's surrounding environment result in pre-planned or ongoing actions becoming
unexpectedly inappropriate (e.g. a person must stop crossing the road if a previously
clear road suddenly becomes occupied by a speeding car). While results have been
mixed (e.g. Oosterlaan & Sergeant, 1998, Schachar & Logan, 1990), the ability to
inhibit responses has been found to improve throughout childhood (Williams et al.,
1999; Simpson & Riggs, 2005) , with the most rapid improvements in inhibitory
control being between the ages of 314 - 5 years (Simpson & Riggs, 2005).
Improvements in inhibitory control have also been associated with increasing affect
and behavioural regulation (Denckla, 1995).
1
Barkley (1997) defines a prepotent response as "that response for which immediate reinforcement
(positive or negative) is available or has been previously associated with that response" (Barkley,
1997, pg 229).
2
Furthermore, Barkley (1997) contends that response inhibition is one of the earliest emerging control
processes. Williams et al. (1997) offer further support for such contentions, highlighting that given
the significance of inhibitory control for survival, this developmental pattern would make particular
sense from an evolutionary perspective.
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1.6.1. Model of Response Inhibition
Barkley (1997) contends that in ADHD it is the overall impairment in response
inhibition that leads to secondary deficiencies in four other executive functions (i.e.
working memory, internalisation of speech, self-regulation of affect-motivation-
arousal, and reconstitution), as all are dependent on response inhibition for their
execution. He presents this theory within a hierarchical model, where deficits in
response inhibition - positioned at the top of the model - give rise to difficulties in
these other, lower-order executive functions. This model is outline in Figure I.
Self-regulation refers to any self-directed action that functions to alter the probability
of a subsequent response in order to modify the likelihood of a future consequence
(Barkley, 2000). Given each executive function can be viewed as a type of self-
directed action, self-regulation can be seen as an inherent part of executive
functioning. Thus, effective inhibition is required not only for the control of these
four secondary executive functions but for self-regulation as a whole.
Many of these self-regulation behaviours are observable in early development but, as
the child's cognitive skills progress, these actions may become more private or
internal in nature. Self-regulation may include skills such as the organisation of
behaviour across time, self-directed speech and the ability to take rules or plans into
account (Barkley, 1997). Thus, resisting temptation, delaying gratification and
executing novel responses are all actions likely to require skills of self-regulation,
and, as such, it is viewed as an inherently future-orientated process (Barkley, 2000).
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Children with ADHD are considered to have problems with self-regulation - this
often presenting as a tendency for them to be influenced by their immediate
environment and imminent consequences (Barkley, 1997). In contrast, children
without ADHD are more influenced by internal information such as past experience,
rules and plans.
Given effective inhibition is regarded as essential in instigating its related executive
functions and self-regulation, it follows that Barkley considers inhibition as the
central deficit of ADHD. He argues that poor sustained attention (once itself seen as
the crux of the disorder) should be seen as a secondary symptom. He claims a deficit
in sustained attention is likely to be due to an underlying impairment in goal-directed
persistence arising from poor inhibition and its associated effect on self-regulation
(Barkley, 1997).
This model tends to dominate a lot of contemporary theory of ADHD and, as such,
the view of response inhibition as the central deficit of ADHD is one which is now
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Figure 1. A schematic configuration of a conceptual model linking behavioural inhibition with the
performance of the four executive functions that bring motor control, fluency, and syntax under the
control of internally represented information iBarklev. 1997).
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1.6.2. An Alternative Model of ADHD
It may be worth noting that, relatively recently, research has emerged to challenge
the dominant notion of response inhibition as the core deficit in ADHD. Sonuga-
Barke et al. (1994) argued that most of the evidence supporting ADHD as a result of
cognitive dysregulation was confounded by delay. Sonuga-Barke and her
colleagues (1992) found that when children were asked to choose between a small
immediate reward and a large, delayed reward, children considered as hyperactive,
were more likely to choose the smaller immediate reward. However, such strategies
were only chosen if they reduced the overall delay period. When choosing the small
reward resulted in the same overall delay period as choosing the larger, postponed
reward, hyperactive children were able to wait as well as the group of control
children.
Furthermore, while children with ADHD were consistently found to make more
impulsive responses and more errors on the matching figures test, Sonuga-Barke et
al. (1994) pointed out that these studies were effected by trial constraints (i.e. as soon
as one trial ended another began) and, as such, were confounded with delay. When
these experiments were repeated in such a manner that early or impulsive responses
had no influence on delay, the responses from children with ADHD were comparable
with that of controls. Such findings lend support for a 'delay aversion' hypothesis
(Sonuga-Barke et al., 1996) in which it is argued that the cognitive deficits thought to
be shown by children with ADHD could actually be more motivational in nature -
i.e. children with ADHD are averse to delay. Sonuga-Barke et al. (1996) contend
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that the influence of delay on behaviour is dependent on whether or not the child is in
control of their environment. When the child is in control of their environment, they
can opt to minimise delay by acting impulsively e.g. jumping a queue at the slide
(Daley, 2006). Conversely, when a child is not in control of their environment, or
expected to conform to certain behavioural rules, they may seek to reduce the
subjective experience of delay (e.g. by day-dreaming, fidgeting etc.). Although
recent research by Kerns et al (2001) also found group differences on a measure of
delay-aversion, this effect did not remain significant after controlling for conduct
problems, leading the authors to suggest that most, if not all, of the association
between hyperactivity and delay aversion can be explained by co-occurring conduct
problems, rather than ADHD per se (Kerns et al., 2001).
Thus, despite the emergence of these relatively new concepts, the literature generally
remains dominated by theory citing response inhibition as the central deficit of
ADHD (Barkley, 1997).
1.6.3. Neuropsychological Tests of Response Inhibition
Accordingly, consistent and robust evidence exists to suggest that children with
ADHD do show deficits in tests of response inhibition. Several studies have shown
that, in comparison to controls, children with ADHD show marked impairments in
inhibitory responses across go/no-go tasks (Booth et al., 2005; Hartung et al., 2002;
Charman et al., 2001; Iaboni et al., 1995; Shue & Douglas, 1992), the continuous
performance task (Halperin et al., 1990), the stop signal task (Schachar & Logan,
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1990) and Stroop interference tasks (Gorenstein et al., 1989; Grodinsky & Diamond,
1992; Hougton et al., 1999).
For instance, Shue & Douglas (1992) assessed response inhibition in children with
ADHD aged between 8-12 years, using the Go/No-go task. This assessment acts as a
simple measure of motor inhibition, whereby participants are required to press a
response key as quickly as possible when presented with a "go" signal (S+), but need
to refrain from pressing in response to a "no-go" signal (S-). Responses to the No-go
signal are scored as errors. Results revealed that children with ADHD made
significantly more errors than control children.
In a review of eighteen studies of executive functioning in ADHD, Pennington &
Ozonoff (1996) concluded that executive functioning deficits are consistent in
ADHD. They went on to highlight the measures that were found to be most sensitive
to ADHD - i.e. the Tower of Hanoi (assessing planning ability), Stroop (task of
inhibition), Matching Figures Test (a measure of impulsivity), the Trail Making Test,
Part B (assessing flexible set-shifting), in addition to 'purer' measures of motor
inhibition (e.g. Go/No-go, Stop tasks, NEPSY Inhibition etc). Thus, with a high
proportion of these 'most sensitive' tests tapping processes of inhibition, measures of
inhibition would appear to be particularly sensitive to ADHD.
These contentions are backed by functional magnetic resonance imaging (fMRI)
data. For instance, Booth et al. (2005) assessed both visual selective attention (using
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a task requiring a visual search of a conjunction target in a field of distracters) and
response inhibition (measured with a go/no-go task). While there were limited group
differences in the selective attention task, there were large group differences in the
response inhibition task. In comparison to the brains of control children, children
with ADHD showed significantly decreased activation in the fronto-striatal regions
of interest - the area of the brain considered as the neural basis of response inhibition
(Booth et ah, 2005). The authors interpret these findings as evidence to suggest that
children with ADHD are unable to effectively engage the fronto-striatal brain
network to maintain appropriate behaviours or inhibit inappropriate behaviours, and
concluded that results were consistent with the hypothesis that response inhibition is
a specific deficit in attention deficit hyperactivity disorder (Booth et al, 2005).
Similar findings have also been obtained by Rubia et al. (2001). Using a more
comprehensively modified test of inhibitory control (i.e. the Maudsley Attention and
Response Suppression (MARS) battery, (Rubia et al., 2001)) children with ADHD
were impaired in the 'more demanding' inhibition tasks such as the go/no-go, stop
and reversal tasks - all of which required the inhibition of discrete motor responses.
This was further corroborated by decreased activation in the right prefrontal brain
regions of those with ADHD.
Thus, there appears to be a wealth of evidence offering support for a response
inhibition deficit in children with ADHD, the majority of which appear to be
measured using 'Stop' or 'Go/NoGo' paradigms. Indeed, Oosterlaan et al. (1998)
conducted a recent meta-analysis of eight studies which used the Stop Task to
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examine response inhibition - incorporating a total of 456 children aged 6-12 years.
In seven of the eight studies considered, children with ADHD demonstrated flatter
inhibition functions, indicating significantly poorer response inhibition than controls.
As such, the authors concluded that consistent and robust evidence had been found to
support contentions that poor response inhibition was at the core of the disorder and
claim that this finding may extend to account for the central deficit of other
externalising disorders (e.g. Conduct Disorder) (Oosterlaan et ah, 1998). Findings
have recently been extended from studies looking exclusively at children, and there
is now additional support for a core deficit in behavioural inhibition in adults with
ADHD (Bekker et ah, 2005).
It should be noted, however, that while the majority of studies appear to measure
inhibition using 'Stop' or 'Go/NoGo' paradigms there may be some methodological
limitations of these tasks. For instance, such tests depend on the establishment of a
'well-learned' response (e.g. a simple motor response to a visual/auditory signal),
prior to inducing the inhibition of that response. However, simple reaction times
may not be 'well-learned' and, as such, might not necessitate demands on inhibition
in order to prevent the response (Wright et ah, 2003). In addition, inhibitory function
is believed to have a more general cognitive basis. Thus, many pathological and
developmental changes in inhibitory function are often associated with a broad range
of associated behavioural symptoms such as language and social dysfunction (Wright
et al., 2003). As such, tests that use motor response as a single measure of inhibition
may have limited value.
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Nonetheless, results demonstrating impaired response inhibition in ADHD are not
always consistent. For instance, a recent study by Kerns et al. (2001) tested response
inhibition in children diagnosed with ADHD using both a visual version of the
Go/No Go task alongside the 'Golden' version of the Stroop task (Golden, 1978) - a
measure of verbal inhibitory capacity. Analysis of results showed that only some
measures of inhibition revealed group differences - i.e. children with ADHD did
make a significantly higher number of omission errors on the Go/NoGo Task.
However, with regard to both the rate of commission errors in the Go/NoGo task and
the interference measure of the Stroop task, the performance of children with ADHD
was comparable to that of controls. The authors present a number of possible
explanations for these results. Most notably, they highlight the aforementioned
contentions of Barkley (1997), which suggest that rather than inhibition representing
a unified construct, it may be more appropriately conceived as several components
working in unison (Barkley, 1997). Based on these premises, Kerns et al. (2001)
propose that not all levels of inhibition may be impaired in children with ADHD.
Hence, their performance on tests may vary according to which component of
inhibition is being tapped.
Such contentions are interesting when considering the findings of a recent meta¬
analysis, aimed at examining studies of inhibition which utilise the Stroop task (van
Mourik et al. 2005). A total of seventeen studies, encompassing 1395 participants
aged between 6-27 years, were analysed in an attempt to determine the extent of
any deficits in interference control in children and young adults with ADHD. In the
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Stroop Colour-Word Test (Stroop, 1935), participants are presented with the words
of colours (e.g. red). However, these words are printed in an opposing colour of ink
(e.g. blue). Participants are asked to name the colour of ink in which the word is
printed. Thus, the automatic reading response must be inhibited, while the colour of
the ink is named (Scheres et al., 2003). The authors concluded that, with deficits
either being completely absent or very small, the standard form of the Stroop Colour-
Word task does not provide strong evidence for a deficit in interference control in
children with ADHD.
However, whilst alleging to use the traditional method of calculating the interference
score in order to yield a 'purer measure' of interference, the authors do acknowledge
that the findings were strongly influenced by the particular type of scoring method.
They also highlight the possibility that the standard Stroop Colour-Word Task may
not serve as a valid measure of interference control in ADHD. For instance, while
the current analysis looked only at studies utilising the standard card-based version
of the task, they contend that a 'trial-by-trial' computerised version of the task may
allow greater sensitivity to attentional pathology, as well as enabling more accurate
measurement of response times and variability. Indeed, when using a computerised
version of the Stroop, differences in reaction times have been detected between
children with ADHD and controls (Carter et al., 1995). However, these results failed
to be replicated in a subsequent study (Gaultney et al., 1999).
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In addition, numerous other studies have made use of the Stroop Task to demonstrate
evidence of a deficit in response inhibition in children with ADHD (e.g. Houghton et
al., 1999; Grodinsky & Diamond, 1992). Indeed, although unclear which versions of
the Stroop were employed, Pennington & Ozonoff (1996) referred to the Stroop as
one of the measures which demonstrated the most consistent impairments in children
with ADHD. Furthermore, subsequent discriminant analysis revealed that the Stroop
was one of the most consistent measures in discriminating children with ADHD -
yielding significant discriminating power in all three of the studies assessed
(Pennington & Ozonoff, 1996).
VanMourik et al. (2005) highlight reasons why Stroop-type tasks may yield
conflicting results. For instance, children with ADHD have been observed to have
naming deficiencies (Tannock et al., 2000). As such, their lower score may be due to
slower rapid naming instead of poor interference control. Additionally, not all
studies control for reading ability. This is especially relevant given the high rates of
co-morbidity between ADHD and reading disorder (e.g. August & Garfinkel, 1990).
If a child cannot read well, it will likely be easier for them to ignore word-meaning
which could potentially lead to relatively faster responses and less interference in
kids with co-morbid ADHD and reading difficulties. Although vanMourik et al.
(2005) found no significant difference in the interference score between children
with ADHD and children with ADHD and a comorbid reading disorder, the
previously described methodological weaknesses may have been masking such
effects.
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Such concerns have been addressed by more recent, alternative versions of the
Stroop-task. These adaptations tend to have the same underlying principle as the
original Stroop-task but present their stimuli in the form of pictures. A number of
such measures are now available for use e.g. the Day-Night Task (Gerstadt et al.,
1994) as well as the 'Fruit Stroop' task (Archibald & Kerns, 1999). In addition,
Wright et al. (2003) recently presented a new, pictorial 'Animal Stroop' measure of
inhibitory function which appears to be appropriate for use with younger children,
and those with reading difficulties (Wright et al., 2003). What's more, within a
school-based sample, initial research suggests that the Animal Stroop appears to
identify those at risk of hyperactive symptomatology (Wright et al., 2003).
Overall then, while there is a strong neuropsychological evidence-base for a response
inhibition deficit in ADHD, findings are mixed and may depend on the type of
measure used. It may be possible that certain methodological limitations, both of the
studies' design and of the tests used, are responsible for the inconsistent nature of
results. The possibility that different tasks tap distinct components of inhibition -
which may or may not be affected by ADHD (Kerns et al., 2001) - might also offer a
potential explanation for the discrepancy of findings.
1.7. Current Treatment of ADHD
A wide range of pharmacological and non-pharmacological therapies have been tried
and continue to be used to treat ADHD, including one-to-one therapy, dietary
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interventions, allergy treatments, biofeedback, play therapy etc. (Pelham et al.,
1998).
However, many have failed to demonstrate their effectiveness as a treatment for
ADHD. For instance, current guidelines on ADHD in Children and Young People
stipulate that there is no established evidence base allowing specific dietary or
alternative therapies to be recommended (SIGN, 2001).
Within the literature, there is a general consensus that only three treatments have
been validated as effective short-term treatments for ADHD - behaviour
modification, central nervous system stimulants and a combination of these therapies
(Pelham et ah, 1998).
1.7.1. Psychotherapeutic Interventions for ADHD
The extensive use of psychotherapeutic approaches in managing the behavioural
difficulties associated with ADHD has generated a lot of investigation examining the
effectiveness of such programmes. Some of these techniques focus on the child's
parent and/or teacher while others concentrate on the child themselves. Such
techniques might include educating parents and teachers about the nature of ADHD
in order to facilitate understanding and promote realistic expectations of the child,
providing them with simple strategies to reduce behaviour problems by adapting the
child's environment and training them in behaviour-management skills. Direct
interventions with the child may involve teaching the child skills of self-control and
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self-monitoring and may have quite specific aims e.g. attention training or anger
management.
While the effectiveness of programmes aiming to train parents in behavioural
management techniques varies across individuals, they have been shown to reduce
conflicts and non-compliance in children with ADHD (Barkley et al., 1992). Indeed,
applying Task Force Criteria for empirically supported treatments, Pelham et al.
(1998) concluded that both behavioural parent training and classroom-based
behavioural interventions were effective in treating ADHD. The authors went on to
separate the parent and classroom interventions into four categories - clinical
behaviour therapy; direct classroom management, cognitive behavioural intervention
and intensive packaged behavioural treatments. Overall, results suggested that
cognitive behavioural treatments do not provide clinically significant improvements
in the behaviour or academic performance of children with ADHD. It is worth
noting that this conclusion contrasts with previous meta-analyses where cognitive
interventions have been deemed as effective in treating impulsivity (Baer & Nietzel,
1991). However, such research was laboratory based and did not involve diagnosed
and/or clinically referred children, thus restricting the generalisability of results. On
the other hand, behaviour modification or contingency management showed
considerable benefits over all studies assessed (Pelham et al., 1998).
A number of limitations of this study should be noted. The authors failed to outline
the details of the requirements on which they were assessing the studies and also
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gave few details regarding their search strategy or inclusion criteria. Such
shortcomings have led other researchers to question whether important studies may
not have been included (Guevara & Stein, 2001). Furthermore, the studies reviewed
only covered children of elementary or pre-school-age, thus findings may not be
generalisable to adolescents or adults with ADFID (Pelham et al., 1998)
Certainly, the research examining the outcome of psychotherapeutic research is
mixed and often overshadowed by the wealth of research looking at pharmacological
techniques. For example, a recent review by Klassen et al. (1999) concluded that
behavioural therapies alone were not efficacious. Although not more efficacious
than pharmacological treatment, combination therapy (i.e. behavioural therapy and
pharmacological therapy) was found to be more effective than no treatment, placebo
and behavioural therapy alone. However, improvements in behaviour were
perceived by parents only and did not extend to the views of the teachers.
Despite reaching these conclusions, the authors do draw attention to the fact that
their findings are somewhat limited by the imbalance of treatment modalities
included in their review. Out of a total 26 papers examined, only two of the studies
looked at behavioural treatments, with a further three assessing combined treatments.
All of these studies were considered relatively poor methodologically and all were
based on only small sample sizes. Nonetheless, reviews such as these, often lead to
researchers concluding that there is an absence of positive outcome studies with
regard to the effectiveness of psychotherapeutic approaches in the treatment of
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ADHD (Brown and Levers, 1999). Furthermore, even when these programmes do
appear to have some success, improvements tend to be temporary and not
generaliseable to more natural environments (Hinshaw et al., 1998).
The validity of research examining psychotherapeutic approaches is often
compounded by a number of factors. Unlike evaluations of stimulant medications, it
is much more difficult to run highly controlled experimental studies looking at
behavioural treatments. Children with ADHD demonstrate various combinations of
problems and often differ in the way they present to clinicians, parents, teachers and
their peers. As such, needs vary depending on the individual child. However, the
research literature combines these ADHD cases by convenience and assesses
predetermined therapy programmes without considering individual needs and
differences. It may be that such mechanisms can account for the weak and
inconsistent findings for psychotherapeutic types of interventions (Klassen et al.,
1999). Furthermore, many of these studies are often limited to short-term evaluation
and fail to follow-up the child or extend investigations into their natural
environments (SIGN, 2001).
It should be noted that while there may be a lack of evidence to support
psychotherapeutic techniques with regard to treating ADHD symptoms per se,
combination therapies are often used in the treatment of co-morbid conditions and
psychotherapy can be used to address some of the resulting problems of living with
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ADHD, such as the effects of the disorder on self-esteem and family functioning
(SIGN, 2001).
1.7.2. Pharmacological Treatments for ADHD
It is estimated that up to 90% of children diagnosed with ADHD receive a
medication trial at some point in their lives (Gadow, 1979). As such, the use of
medication for the treatment ofADHD is a particularly well studied topic, generating
more research than any other area of child and adolescent psychopharmacology
(Coghill, 2003). Currently, there are three main types of medication used -
psychostimulants, nonstimulant-noradrenergic reuptake blockers and (alpha)-agonist
antihypertensive agents (DeNisco et ah, 2005). Psychostimulants are the most
commonly prescribed psychotropic agent for children. These typically come in the
form of short-acting immediate release stimulants, such as methylphenidate.
Methylphenidate is believed to work by affecting neurotransmitters within the
frontostriatal regions of the brain. As mentioned, it has been suggested that people
with ADHD may have an excess of dopamine transporters, thus resulting in low
levels of dopamine within the brain. As dopamine is associated with motivation and
reward (Himelstein et ah, 2000; Volkow et ah, 2001), the low levels found in ADHD
may give rise to many of the symptoms which characterise the disorder e.g. poor
response inhibition, impulsivity, inattention and hyperactivity. Methylphenidate
works by influencing the processes involved in the uptake and release of dopamine,
thus maintaining adequate levels of this neurotransmitter within the brain. By doing
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so, methylphenidate allows interest in less motivating tasks to be maintained, and
performance to be improved (Volkow et al., 2001).
Methylphenidate has a 1 -4 hour duration and a half-life of 2-3 hours. Because of its
short half-life, it is administered three times a day, eliciting concerns regarding
compliance, privacy and stigmatisation (DeNisco et al., 2005). Such problems have
led to the development of several long-acting formulations of psychostimulants,
which are becoming increasingly popular with clinicians, patients and their families.
These include a number of once-a-day preparations of methylphenidate (Concerta,
Metadate CD and Ritalin LA) which act by:
"carrying the active stimulant molecule through a slow-release biphasic delivery
system" (Denisco et al., 2005, pg. 17).
Indeed, there is evidence to suggest that stimulant medication significantly improves
both the classroom and social behaviour of children with ADHD (Pelham, 1986). In
a recent review of eighteen studies, Miller et al. (1998) found that, in comparison to
placebo, methylphenidate, dextroamphetamine and pemoline treatments all resulted
in significantly superior teacher ratings of behaviour.
Contentions of improved functioning are also supported by the neuropsychological
evidence. In comparison to unmedicated ADHD controls, children receiving
stimulant treatment demonstrate enhanced performance on tests of executive
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functioning, including spatial working memory, set-shifting and planning (Kempton
et al., 1999). This is in contrast to animals and human controls, whose executive
functioning skills are impaired by such drugs (Dyme et ah, 1982). Such
psychotropics can also improve attentional processes. For instance, a recent study by
Hood et al. (2005) found that, following administration of methylphenidate, children
with ADHD demonstrated significant improvements in the Test of Everyday
Attention - a neuropsychological battery designed to assess various aspects of
cognitive attention.
1.7.3. The Effects of Medication on Response Inhibition
With stimulant medication being recommended as the first-line treatment in ADHD
(NICE, 2000), and the dominant neuropsychological theory citing response inhibition
as the cardinal feature in ADHD (Barkley, 1997), it is perhaps unsurprising that
recent research has begun to look at the relationship between these factors.
A recent study used the Go/NoGo task, alongside a number of electrophysiological
measures, in order to examine the effects of methylphenidate on response inhibition
in children with ADHD (Broyd et al., 2005). In terms of task performance, the
ADHD group were found to make more overall errors (omission and commission) in
the pre-medication condition. After receiving medication, the ADHD group
continued to make more omission errors than controls, but no longer differed from
controls with regard to the number of commission errors. The authors interpreted
this as evidence that methylphenidate does ameliorate deficits in response inhibition
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and these behavioural findings were further substantiated by the electrophysiological
findings of reduced skin conductance levels, overall supporting a hypoarousal model
ofADHD (Broyd et ah, 2005).
Scheres et al. (2003) investigated the effect of methylphenidate and placebo on
response inhibition in 23 boys with ADHD. However, in this study, response
inhibition was broken down and assessed specifically in relation to the proposed
three components - i.e. inhibition of a prepotent response, inhibition of an ongoing
response, and interference control. Inhibition of a prepotent response was measured
using two versions of the Stop Paradigm. A Circle Tracing Task and a Follow Task
was used to assess inhibition of an ongoing response, while both the Stroop Colour-
Word Test and an Eriksen Flanker Task (where subjects have to suppress an
automatic reading response to irrelevant stimuli, adjoining the target) were used to
measure interference control. Results revealed that, compared to placebo, inhibitory
control did improve with methylphenidate. However, this effect was only significant
for inhibition of a prepotent response and the Follow Task measure of inhibition of
an ongoing response. In contrast, there was no significant effect of methylphenidate
on interference control. This is in contrast to the findings of a previous study where,
in comparison to pre-treatment baseline assessment, Stroop performance was
reported to have improved following one year ofmethylphenidate treatment (Everett
et al., 1991). Although the study also investigated the effects of methylphenidate
dose by employing four treatment conditions: placebo, 5mg MPH, lOmg MPH,
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20mg methylphenidate, there were no effects of medication dosage on any of the
response inhibition measures.
Overall then, pharmacological techniques have generally been found to improve both
the behavioural and neuropsychological performance of children with ADHD. It
should be noted, however, that concerns have been raised with regard to the use of
psychostimulant medication for children, particularly young children, with ADHD.
Perring (1997) highlights ethical issues pertaining to the use of medication to modify
children's behaviour. Pelham et al. (1998) go on to raise concerns about the limited,
short-term effectiveness of these stimulants and others have expressed disquiet about
the lack of information regarding the potential long-term side-effects that these drugs
may have on children's physical and neurological development (Sonuga-Barke et al.,
2003).
Given these concerns and an on-going question over the best long-term treatment for
ADHD, the US National Institute ofMental Health sponsored an ongoing, multi-site
treatment study of children with ADHD - i.e. The Multimodal Treatment Study of
Children with ADHD (MTA).
1.7.4. Combination Therapy and the MTA Study
Given pharmacotherapy is considered efficacious as a stand-alone treatment (e.g.
Klassen et al., 1999) it might be expected that a combination of drug therapy
alongside another type of therapy would be as at least (if not more) effective.
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However, results appear to offer only minimal support for this expectation. For
instance, reviewing three studies which measured outcome using behavioural ratings,
Miller et al. (1998) concluded that combined treatments did not differ significantly
from drug treatment alone. Similar results were found in four out of the five studies
reviewed by Jadad et al. (1999).
To address these issues in more detail, the US National Institute of Mental Health
conducted a large-scale Multimodal Treatment Study of Children with ADHD (MTA
Cooperative Group, 1999). The study involved a total of 579 children aged seven to
nine years who were allocated to one of four treatment divisions and assessed over
14 months. The study compared medication management, behavioural treatment,
combined treatment and standard community care. Results showed that combined
and medication-only therapies were superior to behavioural treatments and
community care with regard to reducing the symptoms ofADHD.
Although, the MTA is potentially the most rigorous study of its kind to date, it has
been the subject ofmuch criticism. Rubia & Smith (2001) argue that the
"positive outcomefor medication was predetermined by the study design" (Rubia &
Smith, 2001, pg 313).
Indeed, on closer examination, many aspects of the study do seem biased in favour of
the medication management condition. For instance, both the quality of care and
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drug dosages were considerably higher in the medication management condition in
comparison with standard community care (Jensen et ah, 1999). Greene and Ablon
(2001) also discuss the imbalance between the extents to which treatments were
individually tailored. While drug treatment was comprehensively tailored to meet
each child's individual needs, there was very little difference in the treatment regime
delivered to children in the psychosocial intervention group. More significantly, no
theoretical justification was provided for the strategies incorporated within the
behavioural intervention leading some authors to query whether aspects of the
programme were actually counterproductive (Morrell & Murray, 2003). Even if
theoretically sound, the utility of the psychosocial intervention appears dubious, with
claims that it would be impossible to replicate in more natural, clinical settings
(Greene & Ablon, 2001). Furthermore, while those children in the medication
management condition were actively receiving treatment at the time of outcome
measurement, the level of input in the psychosocial condition had, by that stage, been
tapered considerably (Jensen et al., 1999).
More thorough inspection of the data revealed a number of effects which have a
considerable impact on the initial interpretation of results. Firstly, children in the
medication management condition received higher doses of medication than those in
the combined treatment (Jensen et al., 1999). Thus, combined treatment produced
comparable outcomes using lower drug dosages, raising a question over whether the
combined treatment approach would have emerged superior had drug doses been
kept equal (Rubia & Smith, 2001). Although behavioural treatment was found not to
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differ from standard community care on the three core symptoms of ADHD, it was
found to be as good as medication management on almost all of the 16 associated
ADHD symptoms, such as parent and teacher rated social-skills, relationships and
academic achievement (Jensen et ah, 1999). Concerns have also been raised over the
potentially deleterious effect of the combined group having received medication
before beginning behavioural treatment (Rubia & Smith, 2001). Finally, like many
of the major studies and reviews regarding treatment in ADHD, the study failed to
determine whether results were applicable to an older adolescent and/or adult
population (Rubia & Smith, 2001).
Nonetheless, based on the originally reported findings that psychosocial intervention
made no significant improvements on outcome when combined with medical
treatment (MTA Cooperative Group, 1999) the British National Institute of Clinical
Excellence report (NICE, 2000) recommended that medication should be used as the
frontline intervention for ADHD, only followed by psychosocial interventions if
necessary. It was only after this document was published that subsequent analysis,
employing different outcome measures ofADHD symptoms, revealed that combined
intervention was in fact superior to medical management alone when considering the
long-term effects of treatment (Swanson et al., 2001).
The original study continues to dominate a lot of the current thinking and further
misinterpretations by media and academia have fuelled contentions that medication
alone is the most effective treatment for ADHD (Rubia & Smith, 2001). Thus,
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despite several challenges to these findings (e.g. Daley, 2006; Owens & Hoza, 2003;
Rubia & Smith, 2001), well-titrated medical treatment remains the treatment of
choice for children with ADHD (Hood et al., 2005). Nonetheless, there are
remaining concerns regarding the limited short-term effectiveness of medication
(Pelham et al., 1998), as well as the potential long-term implications that taking these
drugs may have on both the child's physical development (Sonuga-Barke et al.,
2003) and their self-perceptions (Bugental et al., 1977).
1.8. Behavioural Attributions and Locus of Control in Children with ADHD
Behavioural Attributions and Locus of Control in Children with ADHD is an area
attracting growing interest. The focus on attributional effects is based on a social-
cognitive framework within which causal attributions that one offers for others'
behaviour are seen as being influential in guiding reactions to that behaviour (e.g.
Weiner, 1993). For instance, parent attributions have been found to determine
parenting responses to children (Bugental & Johnston, 2000), with parents being
more likely to respond negatively to misbehaviour when they view the child as being
responsible for their actions (Slep & O'Leary, 1998).
Attributions play an important role not only in guiding our interactions with others,
but also in our own self-perceptions. Attributions for one's own behaviour are
viewed as influential in predicting adaptiveness of functioning (e.g. Dweck et al.,
1995; Taylor & Brown, 1988). For instance, an attributional style of seeing success
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as due to external factors might be considered consistent with a helpless or
depressogenic attributional style (see Milich, 1994).
Locus of control has been defined as the awareness of an association between one's
actions and their consequences (Rotter, 1966). People who believe that an outcome is
largely contingent upon their own behaviour are seen as having a more internal locus
of control. Conversely, those with a more external locus of control tend to believe
that outcomes are largely determined by other factors such as luck, fate, chance or
powerful others. Locus of control has been shown to be associated with a number of
different factors, including academic achievement (Nowicki & Kalechstein, 1997),
psychological well-being and beliefs (see Lefcourt, 1983). Locus of control appears
to be an important factor in the choices people make. For instance, a child with an
internal locus of control, who perceives a connection between his or her behaviour,
trying hard at school, and outcome/academic achievement, may be more likely to try
hard at school (Nowicki & Kalechstein, 1997).
Research using measures of locus of control have shown that, in comparison to
control subjects, children with ADHD have significantly higher external locus of
control and are consequently more likely to view their experiences as being outwith
their personal control or due to other, external factors (Hoza et al., 1993; Lufi &
Parish-Plass, 1995).
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This may be of particular concern when we consider that having accurate control
beliefs and positive self-concept have been identified as important coping resources
in relation to a child's ability to manage stress (Beitchman et al., 1992). Given the
various aforementioned stressors associated with ADHD, it would seem important to
examine such characteristics. Also, in view of the fact that successful academic
performance primarily relies on learning new and challenging material, a child's
response to difficult tasks may influence their ultimate success as learners (Milich,
1994). However, despite the clear importance of such factors, the majority of
research focuses on the medical or biological aspects of ADHD, rather than the
personality of the child (Lufi & Parish-Plass, 1995).
1.8.1. Medication and Behavioural Attributions
Some research has attempted to marry both aspects by examining behavioural
attributions in children with ADHD and addressing the potential effect that
medication may have on these processes. This stemmed from several authors (e.g.
Bugental et al., 1977) expressing concern that successful treatment with medication
may have an adverse effect on children's self-perceptions - arguing that it may be
leading them to attribute their behaviour to external factors (e.g. the drug) while
viewing their own efforts/abilities as having a relatively minor role. It has been
speculated that this may result in children becoming reliant on drugs to focus their
attention and effort, meaning that when medication is discontinued, they are left
feeling that they have no way of controlling their behaviour (Rosen et al., 1985). As
such, any potential effect that medication may have on the attributions made, both by
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the child themselves and by others, may have a crucial influence on the child's
overall development.
The existing evidence in this field is varied. Some case studies (e.g. Rosen et al.,
1985) and indirect evidence suggests that medication does lead children to attribute
their behaviour to more external factors. For instance, children with ADHD have
been found to refer to their problems on a physiological basis and report that taking
their medication does help them to control their behaviour (Henker & Whalen,
1980). In addition, a more recent study by Johnston & Leung (2001) involved boys
with ADHD and their parents watching videos of child ADHD symptoms. Whilst
there were few treatment effects in the attribution ratings of the child participants, it
was noted that both parents and children attributed greater control and intent for
negative behaviours during the medication condition. As such, the authors remark
that these attributions:
"...might generally be considered a maladaptive attributional style with negative
ramificationsfor adaptive functioning.'''' (Johnston & Leung (2001), pg 74).
However, these studies have looked at behaviour in more general terms rather than in
the context of performing specific tasks. Furthermore, the latter study used footage
of unfamiliar children, making it unclear whether these results can be generalised to
children's perceptions of their own behaviour.
In addressing such shortcomings, several studies have utilised specific academic
tasks to examine the effects of stimulant medication on children's attributions for
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their performance. For example, Milich et al. (1989) assessed a group of boys with
ADHD on a test of sustained attention - The Continuous Performance Task - during
both 'medication' and 'placebo' conditions. Despite the fact that the boys performed
significantly better on medication compared to placebo, there were no significant
differences in participants' mean self-evaluations and attribution responses across
these conditions. In fact, finding an increased correspondence between performance
and self-evaluations within the medication condition, the authors suggest that
medication may enhance children's ability/motivation to monitor their own
behaviour, leading to better task strategies.
Extending this work, research has compared boys with ADHD's response to failure
under medication and placebo conditions (Milich at al., 1991; Carlson et al., 1993).
Participants were asked to complete a series of word-finding puzzles where success
and failure were manipulated by exposure to solvable and insolvable puzzles.
Milich et al. (1991) found that, following the failure experience, boys made
significantly more external attributions and significantly fewer internal attributions
on medication relative to placebo. As such, the use of medication in the insolvable
condition appeared to reduce their perceived sense of responsibility for failure. On
the other hand, Carlson and colleagues found that boys with ADHD attributed
success to their efforts and failure to task difficulty regardless of medication status
(Carlson et al., 1993). Furthermore, both studies found that, in comparison with the
placebo condition, participants persisted with the insolvable puzzles to a greater
degree whilst on medication. Thus, reviewing the results of both studies together,
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Milich (1994) suggests that medication may somehow ameliorate failure
experiences, while simultaneously facilitating a healthier and more adaptive style of
responding.
In general then, despite some inconsistencies in results, studies using academic-type
tasks tend to conclude that there is no evidence to suggest that medication has a
detrimental effect on children's attributions for their behaviour. Instead these
children typically attribute success to effort and failure to external factors such as
task difficulty (Johnston & Leung, 2001). What's more, findings of increased
external locus of control in children with ADHD appear to be consistent irrespective
ofmedication status (Lufi & Parish-Plass, 1995).
Nonetheless, it seems clear that, in children with ADHD, the effect medication can
have - both on their behaviour directly and the related attributions made for such
behaviour - is hugely important to their overall development. Generally, most of the
studies to date which examine the effects of medication alongside attributional
responses in children with ADHD, measure task performance using tests of sustained
attention and/or assess their social/behavioural conduct. However, there seems to be
limited research looking at the direct effects of medication on response inhibition or
the influence that medication may have on the attributions for performance in such
abilities. Considering response inhibition is now widely viewed as the cardinal




ADHD is a condition that has a significant impact on the lives of individuals and
their families. Individuals with ADHD have been shown to have impairments in
executive functioning (Pennington & Ozonoff, 1996) and findings of deficits in
neuropsychological tests of response inhibition, support the now dominant theory
citing response inhibition as the central deficit of ADHD (Barkley, 1997). Current
recommendations advocate stimulant medication as the first-line treatment for
ADHD (NICE, 2000). Concerns have been raised about the potential for medication
to have an adverse effect on children's self-perceptions - leading them to attribute
their behaviour to external factors, such as the drug, while viewing their own
efforts/abilities as having a relatively minor role (Bugental et al., 1977). This may be
of particular concern when we consider that having accurate control beliefs and a
positive self-concept have been identified as important coping resources in relation to
a child's ability to manage stress (Beitchman et al., 1992). Furthermore, successful
academic performance primarily relies on learning new and challenging material,
thus a child's response to difficult tasks may influence their ultimate success as
learners (Milich, 1994). There is currently very little research looking at the direct
effects of medication on response inhibition or the influence that medication may
have on the attributions for performance in such abilities. Given that response
inhibition is now widely viewed as the cardinal feature of ADHD (Barkley, 1997),
this seems an important area for research to address.
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1.10. Aims
The aim of the current study is to examine whether methylphenidate is effective in
improving response inhibition in children with ADHD. The study will employ a
newly developed measure of response inhibition - the Animal Stroop Task (Wright
et ah, 2003). In addition, the study intends to examine children's own attributions
about their level of response inhibition and will assess this factor across a variety of
variables, including medication status.
1.11. Hypotheses
1. In comparison with control participants, children with ADHD will show more
impaired response inhibition, as measured by their 'reaction time difference' scores,
on the Animal Stroop Task (Wright et ah, 2003).
2. Following their prescribed methylphenidate dose, children with ADHD will show
an improvement in response inhibition as measured by their 'reaction time
difference' scores, on the Animal Stroop Task.
3. In comparison to control participants, children with ADHD will be significantly
more likely to have an externally-based locus of control.
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4. Children who have a more internally based locus of control will demonstrate better
inhibitory control, as measured by their Reaction Time-Difference Score on the
Animal Stroop.
5. Children with ADHD in the unmedicated condition will give lower estimations of
both predicted- and post- performance ratings in comparison with their ratings in the
medicated condition and with the ratings of control participants.
6. There will be a difference between the participant groups in the self-evaluation
ratings of performance:
(a) In comparison to control participants, children with ADHD will be more
likely to attribute their performance to external factors.
(b) Children with ADHD will be more likely to attribute their performance to





A between subjects design was used to investigate the performance of children with
ADHD and a control group on measures of response inhibition, locus of control and
behavioural attributions.
Additional within subjects comparisons were made in the group of participants with
ADHD to compare response inhibition and behavioural attributions in the
'medicated' vs. 'unmedicated' condition.
2.1.1 Power Calculation
Due to the fairly recent release of the Animal Stroop Task as a measure of inhibitory
control, there is currently a very limited amount of research utilising this test.
Nonetheless, using Cohen's (1992) formula for calculating effect size (for tests of
difference) a large effect size was posited from previous research articles of a similar
nature (e.g. Lufi et ah, 1990; Pennington & Ozonoff, 1996; Scheres et ah, 2004).
Based on Cohen's (1992) estimate of sample size (setting power at 0.8 and alpha at
0.05) one-tailed between subjects tests of difference would require that N=20, and




Two groups participated in this study, an experimental group of individuals with
Attention Deficit Hyperactivity Disorder (ADHD) (n= 21) and a control group of
non-ADHD individuals, (n= 25) matched for age, gender and IQ.
Experimental Group
The children in the experimental group were current patients of the Child and
Adolescent Mental Health Service (CAMHS) in the Scottish Borders. All
participants in the experimental group had been given a diagnosis of ADHD by a
consultant psychiatrist or multi-disciplinary team prior to taking part in the study and
were currently being treated with psychostimulant medication.
Control Group
Participants in the control group were recruited from a variety of local schools. They
had had no previous contact with the Child and Adolescent Mental Health Service
and did not have a diagnosis ofADHD.
2.2.1 Inclusion Criteria
To be included in the study, children in the experimental condition had to meet the
following criteria:
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1. Aged between 5-16 years
2. Primary diagnosis ofADHD
3. Be receiving treatment with psychostimulant medication
Children in the control group had to be:
1. Aged between 5-16 years
2. No diagnosis of ADHD
2.2.2 Exclusion Criteria
1. Children who were diagnosed with any other significant mental health
condition (e.g. autistic spectrum disorder) were excluded from the study.
2. Children with a learning disability (IQ below 70 and significant impairment in
adaptive functioning) were excluded.
3. Children with ADHD who were prescribed non-methylphenidate based drugs
(e.g. Atomoxetine) were also excluded.
2.2.3 Ethical Approval
Ethical approval was granted by the Borders Research Ethics Committee (see
appendix 7.2). A detailed discussion of the ethical issues that arose and were




Based on the above criteria, suitable participants for the experimental group were
identified by members of a multi-disciplinary 'ADHD Team', as well as consultant
psychiatrists within the larger CAMH Service. The parents/guardians of potential
participants were contacted by letter and invited to participate (appendix 7.3). They
were sent two, separate versions of the information sheet - one for themselves
(appendix 7.4) and one, age-appropriate version for the child (appendix 7.5).
Consent forms were also included for both parents/guardians and children
(appendices 7.6 and 7.7) and parents/guardians were asked to specify whether they
would prefer their child to be seen at school or at the child and adolescent unit.
Parents/guardians were also informed that it may be possible for the researcher to
visit their child at home and were asked to indicate this preference on the form.
Once consent was received, parents/guardians were contacted by telephone and
arrangements were made to see the child. Details of each child's prescribed
psychostimulant medication were also gained at this point. All participants were
being treated with psychostimulant medications - Concerta XL, Ritalin or Equasym
- but the dosages received by each participant varied dependent on their individual
requirements. The length of time that participants had been receiving




The matching requirements of the control group were established after identifying
participants in the experimental group. Teachers from five local schools were
contacted regarding the study. They agreed to distribute the letters across the various
year-groups required, inviting parents/guardians and their child to take part in the
study (see appendix 7.3). The teachers were asked to select children who were
considered to have no/few difficulties with hyperactivity or attention and who were
not known to have mental health problems. It was recommended that they distribute
invitations to children from a mixture of academic abilities but refrain from selecting
those with significant learning difficulties. As with the experimental group,
parents/guardians and their children each received separate copies of the information
sheet and consent forms and parents/guardians were asked to indicate where they
would prefer their child to be seen. (Appendices 7.4 - 7.7 contain copies of the
information sheets and consent forms distributed to participants in the control group).
2.2.5 Response Rate
ADHD Group
Of the 98 families contacted, 25 consented to participate in the experimental group, a
response rate of 25.51%. Of those 25, four were automatically excluded from the
study due to incomplete data.
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Control Group
Of the 34 families contacted, 25 consented to take part in the control group, a
response rate of 73.53%. All 25 control participants were included in the study.
2.3 Description and Application of Measures
The following section describes the materials used to measure each variable and the
manner in which these were applied.
2.3.1 Estimated Full Scale IQ
Full-scale IQ was estimated using a shortened version of the Wechsler Intelligence
Scale for Children, UK (WISC-III UK, 1991). The WISC-III is a wide-ranging
assessment measure for use with children aged 6-17 years. It yields a full-scale IQ
score by examining verbal and performance abilities, over 13 different subtests. It
takes approximately two hours to complete and provides information regarding the
child's relative skills in different areas compared to a large normative group of
children of the same age and gender. The shortened version employed comprised
one verbal subtest (Vocabulary) and one performance subtest (Block Design). These
two subtests have high correlations with the Full Scale IQ and consistently high
reliabilities (Sattler, 1992). Participants' scaled scores on these subtests were
combined in order to estimate a Full-Scale IQ score based on the method described
by Sattler (1992). The validity of this short form is high (r = 0.906) (Sattler, 1992)
and it is considered to be a good screening combination (Kilian & Hughes, 1978).
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2.3.2 Response Inhibition
Response inhibition was measured using the Animal Stroop task (Wright et al.,
2003). The Animal Stroop task is a relatively new, pictorial modification of the
original Colour-Word Stroop Task (Stroop, 1935). The Animal Stroop task is based
on four exemplar, animal stimuli - a cow, a pig, a duck and a sheep. The task
comprises three conditions. The first is an 'Incongruent Condition' where each of
the animals' heads is substituted with a head from another of the three animal
prototypes. Thus, within the incongruent condition, there are 12 animal-stroop
stimuli. The second condition is a 'Matching Condition' where each of the four
animal prototypes is displayed as a whole animal - i.e. the animal's body is coupled
with the appropriate, matching head. Lastly, the task includes a 'Control Condition'
where the animal's head is replaced by a caricature of a face. The stimuli used in
each of the three conditions are displayed in Figure II.




Figure II. Stimuli used in standard stroop and animal-stroop task
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The Animal Stroop task is based on the premise that facial information is
preferentially processed (Johnson, 1993) and utilized preferentially in semantic
categorization (Quinn & Eimas, 1996). Thus, in both the incongruent and control
conditions, stroop-like interference can be induced by asking the child to name the
animal's body and inhibit a preferred response to identify the head (Wright et al.,
2003). The control task is intended to act as a semantic control in that it contains
similar semantic content as a face, but produces less activation of animal
representations. As such, it is believed to serve as the most appropriate comparison
with the incongruent task (Wright et al., 2003).
The Animal Stroop task comprises three blocks, with twenty four images in each.
The first and third blocks consist of a mixture of incongruent and control images -
twelve of each within a block. The second block contains 'matching' images only.
In blocks one and three, children are required to name the animal's body whereas, in
block two, they are asked to simply name the animal. The difference between
reaction times in the incongruent and control conditions (i.e. 'Reaction Time
Difference') is used as a measure of inhibitory control (Wright et al., 2003). Thus,
blocks one and three are used to provide a measure of response inhibition. The
images are presented on a computer screen and displayed in a random order. Each
picture is shown in one of two orientations - i.e. either with the animal's head to the
left or to the right of the screen. A fixation point is displayed in the centre of the
screen for 0.5 seconds. Following each fixation point, an animal image is presented
for three seconds, during which time the child is required to name the image. After
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three seconds, the image is removed from the screen and is followed by a one second
interval prior to the presentation of the next fixation point.
Before commencing the Animal Stroop Task, participants were shown flashcards of
each of the four animals and asked to name them in order to ensure correct
identification. Following this, participants were given verbal task instructions and
completed a series of 'warm-up' trials. An example image was presented at the start
of each block whereupon the task instructions were repeated. Participants were
required to identify the example image correctly before proceeding with the test (a
copy of the task instructions appear in appendix 7.8).
The accuracy of children's naming was recorded by the experimenter (see appendix
7.9 for a copy of the scoring sheet). Reaction times were recorded by 'voice key',
elicited by the participants' vocal response, with the researcher operating a manual
timing procedure as back-up.
2.3.3 Locus of Control
Locus of Control was measured using the Locus of Control Scale for Children
(LCSC) (Nowicki & Strickland, 1973) - a brief 40-item pencil and paper
questionnaire. The measure is suitable for use with children aged 9-18 years old
and asks questions about the extent to which behaviours and their contingencies are
seen as under the control of self. People who tend to view such matters as being
within their control are more likely to have an 'internal locus of control'.
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Conversely, if the consequences of behaviour are attributed to luck, chance or the
actions of powerful other means, an 'external locus of control' is present. Each item
is rated either 'yes' or 'no' and the total is used to provide a single, dimensional
score of the degree of external/internal locus of control. The scale takes
approximately 10 minutes to complete and has relatively good reliability and validity
(Nowicki & Strickland, 1973). For children under the age of nine, a twenty-six item,
pictorial version of the scale - the Preschool and Primary Nowicki-Strickland
Internal-External Scale (PPNSIE) (Nowicki & Marshall, 1974) - was used. The
PPNSIE allows for a parallel, age-appropriate reliable and valid measure of locus of
control for children aged 4-8 years old (Nowicki & Marshall, 1974). All questions
were read aloud by the researcher and participants' responses recorded. On some
occasions where the child did not understand the question, further verbal information
was provided.
In order to compare the two forms of the test, the percentage of external items was
calculated for each participant. This is recognised as being the primary method of
comparing the two scales (Nowicki, personal contact, 2006).
2.3.4 Self Evaluation and Attribution Questionnaire
Because Locus of Control Scales are often used to measure more general expectancy
and are mainly concerned with the expectation of future events, it has been argued
that they should not be used to predict actions in specific situations or activities
(Fumham & Steele, 1993). On the other hand, attributional measures are more
concerned with the causes of past events (Furnham & Steele, 1993), thus a more
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focused attribution questionnaire was used to assess participants' experience of the
animal stroop task. Due to a lack of standardised measures relating to the specifics
of the tasks employed, the researcher developed this short questionnaire based on
previous research examining attributions (Milich et ah, 1989).
Because children's attributions vary depending on whether they are describing
successes or failures (Bar-Tal & Darom, 1979), participants were asked whether they
felt they would/had done a good or a bad job before and after completing the animal
stroop task. Participants were also asked to predict how well they thought they
would perform on the task. The questionnaire then went on to assess a number of
dimensions based on questions used in a previous study examining attributions by
Milich et al. (1989). Using a 10-point scale, participants were asked to rate (a) how
well they thought they had performed on the task; (b) how easy they thought it had
been to pay attention; (c) how hard they felt they had tried; (d) how lucky they felt
they had been; (e) how hard they thought the task was. Participants in the
experimental group were also required to rate an additional question: (f) how much
they felt their medication had helped them on the task. Finally, participants were
asked to rank the above factors in order from most to least important. Due to the
extra question used with the experimental group, participants with ADFID were
asked to rank the importance of five factors - 'attention'; 'trying'; Tuck'; 'task
difficulty' and 'medicine'. Accordingly, children in the control group were asked to
rank the importance of only four factors - i.e. attention, trying, luck and task
difficulty. A copy of this questionnaire is contained in appendix 7.10.
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2.3.5 Strengths and Difficulties Questionnaire (SDQ)
Although the school teachers had been asked to select control children who they
considered as having few/no difficulties with attention or hyperactivity, the Strengths
and Difficulties Questionnaire (SDQ) (Goodman, 1997) was used as a more formal
measure of assessing levels of hyperactivity in control group participants.
The SDQ is a brief behavioural screening tool used to assess children between the
ages of 3 - 16 years. It comes in a number of informant and self-rated versions. The
questionnaire examines attributes across five different scales - emotional symptoms,
conduct problems, hyperactivity/inattention, peer relationship problems and prosocial
behaviour - each containing five items. Respondents are asked to rate each question
as 'Not True, 'Somewhat True' or 'Certainly True'. A total difficulties score
(ranging from 0-40) is generated by summing the scores from all the scales except
the prosocial scale. Scores can be classified as 'normal'; 'borderline' or 'abnormal'
using bandings outlined by the authors. These bandings were derived with reference
to normative data and differ depending on the type of informant who completed the
questionnaire (i.e. parent or teacher). The reliability and validity of the SDQ are
relatively good and, as such, it is considered as a useful, brief measure of the
adjustment and psychopathology of children and adolescents (Goodman, 2001).
A strengths and difficulties questionnaire was completed for each participant in the
control group - either by their parent(s) or classteacher. All participants in the
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control group scored within the 'normal' range with regard to
'hyperactivity/inattention'.
2.4 Procedure
All participants were tested on a one-to-one basis, in a separate room, either at
school, at the Child and Adolescent Unit or at home. In the minority of cases where
another adult was present, they did not contribute to the assessment. In order to
ensure consistency of the testing procedure, all participants were assessed by the
same researcher.
Experimental Group
Participants in the experimental group were seen on two separate occasions. Each
participant was assessed under two conditions - a 'medicated' condition where they
had taken their prescribed stimulant medication as usual, and an 'unmedicated'
condition where they were assessed following an unmedicated period of at least 12
hours. Arrangements for the day of the 'unmedicated' assessment session were
agreed with parents by telephone and participants prior to meeting with them and
each parent was sent a letter confirming these plans (see appendix 7.11 for an
example). The majority of children were assessed first thing in the day, allowing
participants and their parents to have the option of simply delaying their morning
dose of medication - i.e. participants were able to take that day's dose of medication
by 1 Oam - approximately only two hours later than what would typically have been
the case. For those receiving short-acting psychostimulant drugs administered
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two/three times a day, each subsequent dose was also postponed a further two hours.
In some cases, parents opted for their child to miss their morning/once-daily dose of
medication altogether. In all circumstances, participants and their parents were
informed that the child should return to their usual medical regime the following day.
The researcher contacted each child's school directly to notify them of these
arrangements and respond to any questions or concerns that they had. The GPs of all
participants in the experimental group were also notified by letter (see appendix
7.12) and given the chance to contact the department if they had any queries.
Equal numbers of participants were allocated to the 'medicated' or 'unmedicated'
conditions initially and the condition-type was reversed for their second assessment
session. The period of time between assessment sessions varied for each participant
and ranged from between four and fourteen days (mean = 6.810,SD = 2.040).
In the 'medicated' condition, participants completed the aforementioned measures in
the order presented below:
a) Question 1 of the Attribution Measure - asking the child to predict
their performance on the Animal Stroop task.
b) The Animal Stroop Task
c) The remainder of the Attribution Questionnaire
d) The Wechsler Intelligence Scale for Children - Version III (WISC-
III) - shortened version.
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e) The Locus of Control Scale for Children (LCSC) (for participants
aged 9 years and over) / Preschool and Primary Nowicki-Strickland
Internal-External Scale (PPNSIE) (for participants aged 8 years and
below).
The full testing battery took between 40 and 60 minutes to complete depending on
the participant.
In the 'Unmedicated Condition', participants completed sections a-c. In this session,
assessment time varied between 15 and 30 minutes.
Control Group
Participants in the control group were seen on only one occasion and completed the
measures as outlined in the above 'Medicated Condition'. During this session, a
Strengths and Difficulties Questionnaire was completed by either the child's parent
or classteacher. As above, assessment time varied between 40-60 minutes for each
of the control participants.
Before commencing each of the measures, all participants received verbal task
instructions and the researcher verified each child's understanding before proceeding
with the test. All participants were informed that they could discontinue at any time.
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All results of the tests and questionnaires were subsequently scored and recorded on
an SPSS database and statistically analysed using SPSS (Statistical Package for the
Social Sciences) for Windows, Version 11.
2.5 Ethical Considerations
Adhering to the British Psychological Society (BPS) Good Practice Guidelines for
the Conduct ofPsychological Research within the NHS (Cooper et ah, 1993),
appropriate steps were taken to ensure that the study was ethical and did not cause
harm. As the research was investigating aspects ofADHD, a disorder which is
primarily reported to affect children, the participation of a child sample was deemed
necessary. However, given that children are classed as a vulnerable population, by
referring to guidance notes on research involving children (University College of
London's Research Ethics Committee, 2006), special consideration was given to
including these participants in the study. Participants and their parents/guardians
were provided with detailed, developmentally-appropriate information sheets (see
appendix 7.4 - 7.5) and also given several opportunities to ask questions, in order
that they could make an informed decision as to whether or not to fully consent to the
research. While all participants assented to participate, given they were all under the
age of sixteen, parental consent was also obtained.
The study method was designed to be appropriate for children and the circumstances
in which the research was conducted provided for the physical, emotional and
psychological safety of the child (University College of London's Research Ethics
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Committee, 2006). As such, parents and children were offered a choice of venue and
parents were also offered the option of being present during testing. Where parents
were not present, the researcher ensured that a contact telephone number was
available in case there were any difficulties. Given the dependent nature of children,
there is a possibility that power differentials may characterize the relationship
between child participants and the researcher. As such, both parents and children
were made aware that they could withdraw from the study at any time and children
were reminded of this option throughout. In view of children's reduced capacity for
full understanding, the assessment procedure was explained to participants in
detailed, developmentally-appropriate language and their understanding confirmed
before commencing with the different measures. Each child was informed that the
test items varied in difficulty and that they should not worry if some were too
difficult as all people got stuck on parts. The researcher encouraged participants
throughout the testing procedure. All participants were thanked for their
participation, both verbally and by letter (see appendix 7.13). Participants, parents
and schoolteachers were given the opportunity to ask questions and were asked if
they wished to receive a summary of the completed study's findings. The
participants were informed that all data would be made anonymous and
confidentiality protected.
In addition, like all proposals involving research with children, the project was
submitted to a research ethics committee and was granted approval (see appendix
7.2).
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Great consideration was also given to the issue of assessing participants in the
Experimental Group 'off medication'. In consultation with the Consultant
Psychiatrist attached to the Borders CAMHS and ADHD Service, it was agreed that
participants would only be required to miss a single dosage of their routinely
prescribed medication prior to only one of two assessment sessions. This process
was considered unlikely to have any significant adverse effects as, due to the
relatively short half-life of stimulant medications, children prescribed these
treatments often experience a dip in medication level during some points of the day
(Pelham et ah, 2001). For example, for each four hours of short-acting
methylphenidate treatment, the medication is likely to be having an effect for only 2-
3 hours. Although the slower release methylphenidate preparations, such as
Concerta, are designed to last 12 hours, children will typically have commenced on a
period of treatment with a shorter-acting stimulant preparation before being changed
over to their longer-acting prescription. In addition, given the link between parents
with a chaotic parenting style and children with ADHD (Johnston & Mash, 2001), it
is not uncommon for children with ADHD to have unintentionally forgotten to take
their medication at times. As such, children are accustomed to feeling 'medication-
free', while parents and teachers are in the habit of managing any associated
behaviours. The researcher was in close consultation throughout the study with the
Child and Adolescent Psychiatrist and parents and children were encouraged to
contact either the researcher or the Psychiatrist if they had any queries.
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The researcher went through the required procedure in depth with each participant's
parent(s). It was arranged for the majority of children to be assessed first thing in the
day, allowing participants and their parents to have the option of simply delaying
their morning dose of medication - i.e. participants were able to take that day's dose
of medication by 10am - approximately only two hours later than what would
typically have been the case. For those receiving short-acting psychostimulant drugs
administered two/three times a day, each subsequent dose was also postponed a
further two hours. In some cases, parents opted for their child to miss their
morning/once-daily dose of medication altogether. Arrangements for the day of the
'unmedicated' assessment session were agreed with parents by telephone and
participants prior to meeting with them and each parent was sent a letter confirming
these plans (see appendix 7.11 for an example). In all circumstances, participants and
their parents were informed that the child should return to their usual medical regime
the following day. Where children were attending school on the day of their
'unmedicated' session, the researcher contacted the school directly to notify them of
these arrangements and respond to any questions or concerns that they had. The GPs
of all participants in the experimental group were notified by letter (see appendix
7.12) and given the chance to contact the department if they had any queries.
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3. Results
The first part of the results section is comprised of descriptive statistics. An outline
of how the data was prepared for analysis will be presented initially. This will be
followed by demographic information about the participants and a description of
subsequent exploratory analyses. The second part of the results section details how
each hypotheses was tested individually using inferential statistics.
Terminology
Inhibitory Control was measured by the Reaction-Time Difference Score of the
Animal Stroop task, therefore the terms 'Inhibitory Control' and 'Reaction Time-
Difference' are used interchangeably.
3.1 Preparation of the data for analysis
The distribution of the variables was investigated by examining the histograms,
skewness and kurtosis scores for each variable (see appendix 7.14). The age and IQ
variables were normally distributed. The other variables - the inhibitory control
score (RT-difference), locus of control score and the individual responses on the
attribution questionnaire - were examined for each group. The data for the reaction
time difference scores and locus of control scores was normally distributed.
However, the data for the remaining variables was not normally distributed in either
of the groups. Approximately half of the variables were negatively skewed, while
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the others were positively skewed. In order to meet requirements for parametric
testing a natural logarithm (x+1) transformation was therefore carried out on each
variable. Transforming this data resulted in normal distributions.
The data was subsequently analysed using parametric tests with SPSS (Statistical
Package for the Social Sciences) Version 11. Parametric tests were considered
optimal due to contentions that they are more powerful (Dancey & Reidy, 2004) and
robust (Clark-Carter, 2004) and, as such, may be less likely to commit Type II errors
(Clark-Carter, 2004). The significance level of test results, unless otherwise stated,




The age of participants with ADHD ranged from 6-14 (mean CA = 9.33, SD = 2.58).
A total of 16 boys and 5 girls participated. Estimated Full-Scale IQ (FSIQ) scores
ranged from 62 - 144 (mean FSIQ = 94.29, SD = 18.16).
Control Group
Participants in the control group were matched with those in the experimental group
for age, gender and estimated FSIQ. Twenty boys and 5 girls took part, aged
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between 6-13 years (mean CA = 9.2, SD = 2.0). Estimated Full-Scale IQ scores
ranged from 71 - 132 (mean FSIQ = 102.48, SD = 17.03).
Using independent samples t-tests, the two groups were statistically compared on age
and IQ. No significant differences were detected. A chi-square showed there was no
significant difference between the distribution of males and females in the two
groups.
Table 1 (below) summarises the results of the tests of difference / association, for the




























t = 1.58 0.12
Gender
M:F
16:5 4:1 X=0.10 0.78
Table 1: Descriptive characteristics of the sample
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3.2.2 Exploratory Data Analysis
Two participants were removed from each of the ADHD group (medicated
condition) and the Control group due to outlier scores on the inhibitory control
measure of the Animal Stroop. These scores needed to be removed in order for the
groups to be matched on the inhibitory control task. Figure III (below) illustrates a
box-plot of the inhibitory control task scores for the experimental (medicated





Figure 111. A box-plot to show the scores on the inhibitory control task for the experimental
(medicated condition") and control groups.
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An ANOVA was used to examine whether there was any effect of the order in which
the experimental participants were tested (i.e. whether they were in the medicated
followed by unmedicated condition or vice versa). The ANOVA showed there was
no interaction between order and group (F = 0.83, p = 0.37, df = 1) - i.e. there was
no combined effect of the two factors (order and group) on Reaction Time Difference
scores (see appendix 7.15). The 'order' variable was therefore removed from further
analysis.
3.3 Hypothesis Testing
Each hypothesis was tested using inferential statistics. Independent- and paired-
samples t-tests were used to investigate hypotheses 1, 2, 3, 5 and 6. Pearson's
correlations were used to investigate hypothesis 4. The results for each hypothesis
are reported below.
Hypothesis 1
In comparison with control participants, children with ADHD will show more
impaired response inhibition, as measured by their 'reaction time difference'
scores, on the Animal Stroop Task (Wright et al., 2003).
In order to investigate hypothesis one, two separate comparisons were made
between: a) Participants with ADHD in the medicated condition (ADHD-medicated)
and Control participants.
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b) Participants with ADHD in the unmedicated condition (ADHD-unmedicated) and
Control participants.
Independent Samples t-tests showed no significant differences in Reaction Time
Difference Scores between either the ADHD-medicated and control groups (t = -
0.98, p = 0.17, df = 44) or between the ADHD-unmedicated and control groups (t =
1.56, p = 0.06, df = 40). See table 4 and figure IV for a comparison ofmean reaction
time difference scores.
The null hypothesis cannot, therefore, be rejected.




Figure IV. Reaction Time Difference Scores for both the Experimental and Control Groups.
87
ADHD-Medicated ADHD-Unmedicated Controls
X (SD) X (SD) X (SD)
Range Range Range
(n) (n) (n)
RT Difference 39.95 (58.60) 103.86 (103.02) 76.57 (86.99)
-66.00- 141.00 -66.00-298.00 -80.00-262.00
(19) (21) (23)
Table 4. Means. Ranges and Standard Deviations for Hypotheses 1 & 2.
Hypothesis 2
Following their prescribed methylphenidate dose, children with ADHD will
show an improvement in response inhibition as measured by their 'reaction
time difference' scores, on the Animal Stroop Task.
A Paired-Samples t-test showed a significant difference between the reaction time
difference scores of participants with ADHD-medicated and participants with
ADHD-unmedicated (t = 2.28, p = 0.02, df = 18). ADHD participants showed
significantly higher reaction time difference scores in the unmedicated condition
compared to the medicated condition. See table 4 and figure IV for a comparison of
mean reaction time difference scores.
Hypothesis 2 is upheld and the null hypothesis is rejected.
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Hypothesis 3
In comparison to control participants, children with ADHD will be significantly
more likely to have an externally-based locus of control.
An independent samples t-test showed there was no significant difference between
the locus of control scores of experimental participants and participants in the control
group (t = -0.77, p = 0.22, df = 44). See figure V for a comparison of the mean
percentage of externality scores across the two groups. Comparisons were made
using the mean percentage of external items yielded by each participant group.
In the case of hypothesis 3, the null hypothesis cannot be rejected.






Figure V. A Comparison of External Locus ofControl Scores across Participant Groups
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Hypothesis 4
Children who have a more internally based locus of control will demonstrate
better inhibitory control, as measured by their Reaction Time-Difference Score
on the Animal Stroop.
Pearson's Correlations detected no significant relationships between Locus of
Control scores and reaction time difference scores in any of the three conditions - i.e.
ADHD-medicated (r = -0.08, p = 0.38, N = 19); ADHD-unmedicated (r = 0.26, p =
0.13, N = 21); Controls (r = 0.05, p = 0.41, N = 23) - or for all participants combined
(r = 0.09, p = 0.24, N - 63).
As such, the null hypothesis cannot be rejected.
Hypothesis 5
Children with ADHD in the unmedicated condition will give lower estimations
of both predicted- and post- performance ratings in comparison with their
ratings in the medicated condition and with the ratings of control participants.
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Predicted Performance Ratings:
Using paired-samples t-tests, a significant difference was found between the two
experimental group conditions on the predicted performance rating completed before
the task (t = 2.15, p = 0.02, df = 20). Participants with ADHD were significantly
more likely to predict a poorer performance in the unmedicated condition in
comparison to the medicated condition. The means and standard deviations are
presented in table 5.
An independent-samples t-test detected no significant difference between the
predicted performance ratings of control participants and participants with ADHD in
the unmedicated condition (t = 1.57, p = 0.06, df = 44). However, the predicted
performance ratings provided by the ADHD participants during the medicated
condition were significantly higher than those given by children in the control group
(t = -1.86, p = 0.04, df= 44). See table 5.
Post-Performance Ratings:
A paired-samples t-test detected no significant difference between the post-
performance ratings of children with ADHD across the medicated and unmedicated
conditions (t = -0.80, p = 0.22, df = 20).
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Similarly, independent samples t-tests detected no significant differences between
the control participants and participants with ADHD in the medicated condition (t =
0.46, p = 0.32, df = 44) or between control participants and participants with ADHD
in the unmedicated condition (t = 0.40, p = 0.35, df = 44).
A comparison of the mean scores for predicted and post-performance ratings across



























Table 5. A Comparison of the Mean Predicted- and Post- Performance Ratings for all Conditions
(Based on the Transformed Data)
Hypothesis 5 is therefore upheld in part. Children with ADHD in the unmedicated
condition did give significantly lower estimations of predicted performance ratings in
comparison with their ratings in the medicated condition. However, as there was no
significant difference between the predicted performance ratings of children with
ADHD in the unmedicated condition and those of control children, nor any
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significant differences between the three groups on post-performance ratings, the null
hypothesis in its entirety cannot be rejected.
Hypothesis 6
There will be a difference between the participant groups in the self-evaluation
ratings of performance:
a) In comparison to control participants, children with ADHD will be more
likely to attribute their performance to external factors.
b) Children with ADHD will be more likely to attribute their performance
to external factors in the unmedicated condition in comparison to the
medicated condition.
a) Independent samples t-tests were used to look for any differences between the
ratings given by the experimental participants and control groups. Irrespective of
experimental condition, no significant differences were detected for any of the self-
evaluation ratings of participants - i.e. ease of paying attention, trying hard, task
difficulty or luck. (See appendix 7.16 for details of the non-significant results).
b) Paired-Samples t-tests were used to compare the experimental group's
performance ratings on the attribution questionnaire across the medicated and
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unmedicated conditions. There were no significant differences between groups for
any of the self-evaluation ratings. (See appendix 7.16 for details of the non¬
significant results).
The participant responses to the various questions on the Attribution Questionnaire
are shown in figure VI.











Figure VI. Experimental and Control Participants1 Responses to the Attribution Questionnaire.
Further analysis was performed on the responses provided by participants in the
experimental group when ranking the importance of the various factors which
contributed to their performance on the Animal Stroop Task. Paired-samples t-tests
showed that there were no significant differences between the rankings given for any
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of the five variables across the two experimental group conditions (see appendix
7.17). On examining the percentage of responses allocated to each variable, there
was a similar breakdown across the two groups, as can be seen from figures VII &
VIII.
Ranking Importance of Factors Contributing to Task Performance
ADHD Group - Medicated
Ranking Importance of Factors Contributing to Task Performance







Figure VII. The Importance Ranking of Factors
Contributing to the Task Performance of ADHD





Figure VIII. The Importance Ranking of Factors
Contributing to the Task Performance of ADHD
Participants' in the Unmedicated Condition
With regard to both parts a) and b) of hypothesis 6, the null hypotheses cannot be
rejected.
3.3.1 Summary of Hypotheses Testing
Hypothesis 1 - There was no significant difference between the inhibitory control of
children with ADHD and those of children in the control group.
Hypothesis 2 - In comparison to the unmedicated condition, children with ADHD
showed a significant improvement in inhibitory control following their prescribed
methylphenidate medication.
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Hypothesis 3 - There was no significant difference between the locus of control
scores of children with ADHD and children in the control group
Hypothesis 4 - There was no significant relationship between locus of control and
inhibitory control in any of the participant groups.
Hypothesis 5 - The predicted performance ratings of children with ADHD were
significantly lower in the unmedicated condition compared to their ratings in the
medicated condition. However, there was no significant difference between the
predicted performance ratings of children with ADHD in the unmedicated condition
and those of control children, nor any significant differences between the three
groups on post-performance ratings.
Hypothesis 6 a) Children with ADHD and children in the control group did
not differ significantly in the degree to which they attributed their performance to
external factors.
b) There were no significant differences between the degree to
which children with ADHD attributed their performance to external factors across
the medicated and unmedicated conditions.
All non-significant results are displayed in appendices 7.16 - 7.17.
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4. Discussion
This study examined whether methylphenidate is effective in improving response
inhibition in children with ADHD, using a newly developed measure of response
inhibition - the Animal Stroop Task (Wright et ah, 2003). In addition, the study
looked at children's own attributions for their level of response inhibition across a
variety of variables, including medication status.
The discussion will initially outline the results in relation to each of the hypotheses
and discuss these in turn. This will be followed by a consideration of the
methodological limitations as well as clinical and ethical implications of the study,
before ending with suggestions for further research.
4.1. Interpretation of the results
Hypothesis 1 - There was no significant difference between the inhibitory control of
children with ADHD and those of children in the control group. This suggests that
children with ADHD (irrespective of whether they are being treated with
methylphenidate medication) do not differ from children without ADHD with regard
to their level of inhibitory control. As such, the null hypothesis could not be
rejected.
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Hypothesis 2 - In comparison to the unmedicated condition, children with ADHD
showed a significant improvement in inhibitory control following their prescribed
methylphenidate medication. This suggests that methylphenidate is effective in
improving the inhibitory control of children with ADHD and, as such, hypothesis 2
was upheld.
Hypothesis 3 - There was no significant difference between the locus of control
scores of children with ADHD and children in the control group. This suggests that
children with ADHD are no more likely to attribute their experiences to external
factors than normally developing children are. The null hypothesis could, therefore,
not be rejected.
Hypothesis 4 - There was no significant relationship between locus of control and
inhibitory control in any of the participant groups. This suggests that children with a
more internal-based locus of control are no more able to manage their inhibition than
children with a more external locus of control. The null hypothesis could, therefore,
not be rejected.
Hypothesis 5 - The predicted performance ratings of children with ADHD were
significantly lower in the unmedicated condition compared to their ratings in the
medicated condition. Furthermore, children with ADHD in the medicated condition
gave significantly higher predicted performance ratings than children in the control
group. In contrast, there was no significant difference between the predicted
performance ratings of children with ADHD in the unmedicated condition and those
of control children, nor any significant differences between the three groups on post-
performance ratings. This suggests that, when medicated, children with ADHD tend
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to predict a better performance compared to situations where they have not received
medication, and in comparison to normally developing children. With regards to
actual-performance, however, all groups rate their performance comparably. Thus,
despite hypothesis 5 being upheld in part, the null hypothesis, in its entirety, could
not be rejected.
Hypothesis 6 a) Children with ADHD and children in the control group did
not differ significantly in the degree to which they attributed their performance to
external factors.
b) There were no significant differences between the degree to
which children with ADHD attributed their performance to external factors across
the medicated and unmedicated conditions.
This suggests that, irrespective of medication status, children with ADHD are no
more likely to attribute their task performance to external factors than normally
developing children. The null hypothesis could, therefore, not be rejected.
4.2 Discussion of the Results
The findings of the various hypotheses will be discussed in relation to each variable





Hypothesis 1 stated that, in comparison with control participants, children with
ADHD would show more impaired response inhibition, as measured by their
'reaction time difference' scores, on the Animal Stroop Task (Wright et ah, 2003).
However, statistical analysis showed that there were no significant differences in
Reaction Time Difference Scores between either the ADHD-medicated and control
groups or between the ADHD-unmedicated and control groups, suggesting that
children with ADHD (irrespective of whether they are being treated with
methylphenidate medication) do not differ from children without ADHD with regard
to their level of inhibitory control.
This goes against the now wide-spread theory of response inhibition as the central
deficit of ADHD (Barkley, 1997) and is in opposition to previous research which
contends that, in comparison to controls, children with ADHD have significant
impairments in inhibitory responses across go/no-go tasks (Booth et al., 2005;
Hartung et al., 2002; Charman et al., 2001; Iaboni et al., 1995; Shue & Douglas,
1992), the continuous performance task (Halperin et al., 1990), the stop signal task
(Schachar & Logan, 1990) and Stroop interference tasks (Gorenstein et al., 1989;
Grodinsky & Diamond, 1992; Hougton et al., 1999).
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There could be a number of possible explanations for why the current study failed to
find a difference between the inhibitory control of children in the control and
experimental groups. The majority of the studies that document deficits in response
inhibition in children with ADHD use 'Go/NoGo' (e.g. Shue & Douglas, 1992; Booth
et al. 2005; Rubia et al. 2001) and 'Stop' paradigms (Oosterlaan et al., 1998).
However, as mentioned previously, there are a number of limitations with these
measures. Such tasks comprise pure measures ofmotor inhibition and simple motor
reaction times may not be so well-learned to the extent that they necessitate demands
on inhibition in order to prevent the response (Wright et al., 2003). It could be that
while these tasks provide a measure of motor inhibition, they may fail to tap into
inhibitory control more broadly e.g. across a cognitive and behavioural level (Wright
et al., 2003). On the other hand, measures such as the Stroop task rely on vocal
responses. Such reactions may be better established and, consequently, more
automatic, making higher demands on inhibitory control in general.
Indeed, studies measuring inhibitory control with the colour-word version of the
Stroop task often fail to find impairments in response inhibition in children with
ADHD (e.g. Kerns et al., 2001; vanMourik et al., 2005). Such results could be
interpreted as evidence that, once the motor component of response inhibition is
removed, children with ADHD do not display any deficit in inhibitory control.
Nonetheless, other researchers have demonstrated such deficits by using the same
Stroop task (e.g. Houghton et al., 1999; Pennington & Ozonoff, 1996; Grodinsky &
Diamond, 1992). Given the high rates of co-morbidity between ADHD and reading
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disorder (August & Garfinkel, 1990), the fact that many of these studies fail to
control for reading ability has been put forward as a possible explanation for these
conflicting results (vanMourik et al., 2005). However, measures such as the Animal
Stroop task, which use pictorial images rather than words, should be devoid of such
shortcomings.
As such, the failure of the current study to find an inhibitory control deficit in
children with ADHD may be more representative of Kerns et al.'s (2001) contentions
that different tasks may tap different components of inhibition and that not all levels
of inhibition are necessarily impaired in children with ADHD (Kerns et al., 2001).
Thus it is possible that inhibitory control, as measured by the Animal Stroop, might
not be affected by ADHD. It may, then, have been useful for this study to have
employed more than one measure of inhibitory control in order to assess the potential
for different components of inhibition more thoroughly.
Alternatively, these results may offer further support for the 'delay aversion'
hypothesis put forward by Sonuga-Barke and colleagues (1996). The delay aversion
hypothesis argues that the cognitive deficits thought to be shown by children with
ADHD could actually be more motivational in nature - i.e. children with ADHD are
averse to delay. As mentioned previously, Sonuga-Barke et al. (1994) highlighted
that studies measuring inhibitory control are often effected by trial constraints (i.e. as
soon as one trial ended another began) and, therefore, are confounded with delay.
When these experiments have been repeated in such a manner that early or impulsive
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responses have no influence on delay, the responses from children with ADHD are
comparable with those of controls (Sonuga-Barke et ah, 1996). The trials in the
Animal Stroop task are of equal length, irrespective of participant's speed of
responding. Thus, the current lack of discrepancy between the inhibitory control of
children with ADHD and children in the control group may be due to the fact that, as
participants could not opt to minimise the delay by acting more impulsively, there
was little motivational incentive for children with ADHD to respond more rapidly.
Nonetheless, these explanations fail to account for the initial findings of Wright et al.
(2003) who, with reference to the behavioural data of a large sample of children aged
between 3 and 16 years, suggested that the Animal Stroop appeared to identify those
at risk of hyperactive symptomatology (Wright et al., 2003). It should be noted,
however, that Wright et al's (2003) findings were based on data gathered from a
school-based sample and only utilised behavioural data gathered from teachers rather
than the cross-situational information required in considering a diagnosis of ADHD.
Thus, the contrast in findings with those of the current study may suggest that using
the Animal Stroop task as a measure of inhibitory control is not sufficient in
differentiating between children with a clinical diagnosis of ADHD and normally
developing children. Given that a deficit in response inhibition is considered to be a
cardinal feature of ADHD (Barkley, 1997), however, it seems peculiar that the




Given the above failure to detect any difference in the inhibitory control of children
with and without a diagnosis of ADHD, it may be surprising that analysis of
hypothesis two revealed that, in comparison to the unmedicated condition, children
with ADHD showed significant improvements in inhibitory control after receiving
their methylphenidate medication. These findings fit with the limited, previous
reports of methylphenidate ameliorating deficits in response inhibition as measured
by a Go/No-go task (Broyd et ah, 2005) and by the colour-word version of the Stroop
task (Everett et al., 1991). Such improvements in inhibitory control would also tie in
with the more general reports of stimulant medication improving both the classroom
and social behaviour of children with ADHD (Miller et al., 1998; Pelham et al.,
1998), as well as their performance on attentional measures (Hood et al., 2005) and
various other executive functioning tasks (Kempton et al., 1999).
However, the current findings go against the results of a more recent study by
Scheres et al. (2003) who examined the effects of methylphenidate in relation to the
different components of response inhibition. While methylphenidate produced
significant improvements in the inhibition of a prepotent response and partial
improvements in the inhibition of an on-going response, there was no significant
effect of methylphenidate on interference control (as measured by both the Stroop
Colour-Word Test and the Eriksen Flanker Task).
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It may be possible that the discrepancy in results reflects the different types of Stroop
measures employed. Scheres et al. (2003) employed the colour-word version of the
Stroop. Due to the automatic reading skills required in this task, only children aged 8
and above were tested. However, reading ability was not controlled for directly and,
given the aforementioned increased rates of co-morbidity between ADHD and
reading disorder (August & Garfinkel, 1990), it is possible that reading deficits
within this sample may have rendered the results of the colour-word stroop
inaccurate.
Alternatively, the contrast in results could be due to the differing levels of
methylphenidate received by the children in each study. Scheres et al. (2003)
examined the effects of methylphenidate dose specifically by employing four
different treatment conditions - placebo, 5mg of methylphenidate, lOmg of
methylphenidate and 15/20mg of methylphenidate. Although Scheres et al. (2003)
found no effects of medication dosage on any of the response inhibition measures,
many of the children with ADHD in the current study were receiving doses of
methylphenidate-based medication that exceeded a 20mg dose. Indeed, other studies
have reported an optimal response to medium or high doses of methylphenidate in
cognitive tasks (e.g., Douglas et al., 1988), yet Tannock et al. (1995) found that
inhibitory performance declined in their high dose condition compared to the
medium dose condition. In contrast, a more recent review examining the effects of
low and high doses of methylphenidate on cognitive tasks reported there was no
evidence to support an optimal lower dose (Rapport & Kelly, 1991). Due to the
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assortment of different methylphenidate-based prescriptions received by the children
with ADHD (e.g. long- vs. short-acting preparations), along with the various timings
at which these were taken, it was not felt possible to accurately control for the effects
of methylphenidate dosage in the current study. Thus, it is not possible to ascertain
whether the dosage level of methylphenidate had an effect on the inhibitory control
of participants with ADHD.
It may also be worth noting that all participants within the experimental group of the
current study had been receiving medication for a minimum period of 4 months.
This is in contrast to some of the previous research in which participants are naive to
medication and subsequently experience a period of titration before the study
commences. Although these titration periods are relatively extensive (e.g. four
weeks in the case of Scheres et al., 2003), it is possible that the length of time
participants have been receiving medication has an effect on any subsequently
experienced improvements in response inhibition. Indeed, while Scheres et al.
(2003) found no improvement in response inhibition following methylphenidate
administration, others have reported significant improvements in the inhibitory
control (as measured by the Stroop Colour-Word Test) of hyperactive children
following a year of treatment with methylphenidate (Everett et al., 1991). Again, due
to the variety in the length of time that participants had been receiving
psychostimulant medication (i.e. between 4 and 84 months), changes in medication -
dose and type - that had occurred within this time, alongside the different doses and
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types ofmedication prescribed presently, it was not felt possible to accurately control
for the length of time on medication in the current study.
Given the contrast between results, however, it may be possible that any enhancing
effects of methylphenidate on the interference control component of response
inhibition are subject to influence by the dose and type of medication, in addition to
the length of time medication has been received.
While Everett et al. (1991) did report significant improvements in the inhibitory
control of hyperactive children subsequent to methylphenidate treatment, these
children still performed more poorly than normal controls. In contrast, despite
failing to reach statistical significance, after receiving methylphenidate, children with
ADHD in the current study actually demonstrated superior inhibitory control than
participants in the control group. The pattern of results detected was that medicated
children with ADHD displayed the best inhibitory control, followed by children in
the control group, with unmedicated children with ADHD demonstrating the poorest
performance (see figure IV and table 4 of the results section).
This is an interesting finding, suggesting that the effects of methylphenidate not only
improve inhibitory control in children with ADHD but actually elevate such skill to a
level which is above average. This, perhaps, raises an ethical concern in that
medication may be being used to alter behaviour in children with ADHD beyond that
which is typical ofnormally developing children.
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Given the highly significant improvement in the inhibitory control of children with
ADHD between the unmedicated and medicated condition, along with reports that
stimulants appear to have similar behavioural effects in normal children (Rapoport &
Inoff-Germain, 2002), it would have been interesting to examine the effects of
medication on response inhibition in children within the control group. Such
investigation would have allowed for a comparison of any level of improvement in
inhibitory control between the two groups. However, given the ethical concerns
surrounding this notion, along with the constraints of the current research, it was not
felt possible to pursue this issue further.
4.2.2 Locus of Control
Hypothesis 3
Statistical analysis of hypothesis three showed that there was no significant
difference between the locus of control scores of children with ADHD and children
in the control group. This contradicts previous research reporting that children with
ADHD have significantly higher external locus of control (Lufi & Parish-Plass,
1995; Linn & Hodge, 1982) and are consequently more likely to attribute their
experiences to external, uncontrollable factors (Hoza et al., 1993).
In the current study, children with ADHD completed the locus of control scale in the
medicated condition only. Given the failure to replicate the previous findings of
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increased externality in the locus of control of children with ADHD, it could be
surmised that medication has a direct influence on a child's view of their level of
control, causing them to feel more in control of their own behaviour and
consequently perceiving external factors as being less influential in the experiences
they have. However, although participants in Lufi & Parish Plass' (1995) study were
not (currently or previously) receiving stimulant medication, Linn & Hodge (1982)
reported similarly elevated external scores in their sample of hyperactive males, the
majority of which were receiving drug treatment. Moreover, given previously
published claims that locus of control is a stable personality trait (Reich et al., 1997),
and reports that children with ADHD are more externally orientated regardless of
medication status (Lufi & Parish-Plass, 1995), it was not felt necessary for
participants to complete the locus of control scales in both the medicated and
unmedicated conditions. Nonetheless, in view of the failure to replicate findings of
increased external locus of control in children with ADHD, it may have been useful
to examine whether the locus of control scores of the experimental participants were
indeed influenced by the medication condition of the current study.
It should also be noted that although the same measure of locus of control was
utilised across all three studies, the participants in Linn & Hodge's (1982) study and
Lufi & Parish-Plass' (1995) study were, respectively, comprised of 16 boys from
New Mexico and 28 Israeli boys. While the Locus of Control Scale for Children is
considered suitable for use across a wide variety of countries (Nowicki & Strickland,
1973), in view of the fact that all participants in the current study were of British
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origin, it may be possible that cultural differences were influencing the responses
provided.
Hypothesis 4
Given people with a more internally-based locus of control are more likely to
perceive a connection between their behaviour and the outcome (Nowicki &
Kalechstein, 1997), it was hypothesised that children who have a more internally
based locus of control may demonstrate better inhibitory control (Hypothesis 4).
However, correlation analysis showed that there was no significant relationship
between locus of control and inhibitory control in any of the participant groups. This
is perhaps unsurprising given that children with ADHD were comparable to children
in the control group with respect to both inhibitory control and to locus of control.
However, such findings could also be interpreted as evidence that inhibitory control
is not subject to modification by any degree of conscious personal control and, as
such, may constitute a more biologically-based ability. Tentative support for such
contentions may also be offered by the results of a recent study reporting that, in





Analysis of hypothesis five revealed that the predicted performance ratings of
children with ADHD were significantly lower in the unmedicated condition
compared to their ratings in the medicated condition. While this may be interpreted
as evidence that children with ADHD are significantly more likely to under-predict
their level of performance during times they are not receiving medication, it is worth
noting that there was no significant difference between the predicted performance
ratings of children with ADHD in the unmedicated condition and those of control
children. This would suggest that children with ADHD, without medication, actually
predict their performance at a level comparable to that predicted by normally
developing children. Conversely, the predicted performance ratings provided by the
participants with ADHD during the medicated condition were significantly higher
than those given by children in the control group, suggesting that, prior to
undertaking tasks when medicated, children with ADHD have more confidence in
their ability to perform than normally developing children do. Overall then, although
children with ADHD predict poorer performance levels during periods where they
are not receiving medication, these predictions are still comparable with that of
normally developing children. On the other hand, the performance predictions of
children with ADHD who are receiving medication are significantly higher than
normally developing children and, as such, may be unrealistic.
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Nonetheless, on examination of the original data, however (see appendix 7.18 for
original data and table 5 of the results section for transformed data), it becomes
apparent that, while the ratings of children with ADHD in the unmedicated condition
and the ratings of children in the control group tend to increase following task
completion, there is very little difference between the pre- and post- performance
ratings of children with ADHD in the medicated condition. It could be then, that
both controls and children with ADHD without medication, are more likely to give
lower predicted ratings of their performance as a cautionary measure, yet, after
completing the task, feel sufficiently confident to increase this rating. On the other
hand, children with ADHD who are receiving medication may feel more confident in
their ability to accurately predict their performance from the outset and, as such, feel
less need to under-predict their performance initially.
These findings fit, to some degree, with a growing body of research contending that
children with ADHD may be characterised by overly optimistic self-perceptions
(Hoza et al., 2000). For instance, when reporting self-perceptions at the onset of a
treatment programme, the ratings provided by boys with ADHD, in terms of
academic, social and athletic functioning, were statistically "indistinguishable' from
those of control participants (Hoza et al., 1993). Expanding on this, Hoza et al.
(2000) found that boys with ADHD rated their own performance on a social task
significantly more favourably than control boys did. Indeed, this 'positive illusory
bias' was sometimes even more extreme following a negative social experience.
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From this finding, the authors suggest that inflated self-perceptions may be one way
in which boys with ADHD try to cope with failure. Similar contentions have also
been put forward by Diener and Milich (1997) who propose that enhanced self-
perceptions serve a protective function for children with ADHD by counteracting
feelings of inadequacy.
Indeed, even amongst non-disordered individuals, a positive illusory pattern is
normative and it has been suggested that,
"positive illusions....may be especially apparent and adaptive under
circumstances of adversity, that is, circumstances that might be expected to
produce depression or lack ofmotivation" (Taylor & Brown, 1988, p. 201).
It may be possible, then, that for children with ADHD, inflating their predictions of
performance provides them with a protective, buffering measure against the
possibility of potential failure. Nonetheless, this explanation fails to account for why
these children's predictions become comparable with those of controls when they are
no longer receiving medication. Nor does it account for why there are no significant
differences between the post-performance ratings of children with ADHD, either
across medication conditions or in comparison with controls.
Milich (1994) proposed that medication may somehow ameliorate potential failure
experiences, while facilitating a healthier, more adaptive style of responding.
Indeed, having the ability to believe that something will go well forms the basis of
the widely-advocated use of 'positive self-talk' as a coping strategy throughout the
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child and adolescent literature (e.g. Webster-Stratton, 2006; Carr, 1999). It is
possible then, that when faced with a potential failure experience, medication
afforded participants with ADHD the capacity to generate enhanced self-perceptions,
an ability that was not afforded in the unmedicated condition. Nonetheless, after
completing the task and viewing it as a successful experience (all participants
reported they had done a good job), there was no longer the same need for this
buffer, hence the post-performance ratings of children with ADHD who were
receiving medication remained at a level which became comparable to their post-
performance ratings in the unmedicated condition and with the ratings of controls.
Although a plausible explanation, it should be noted that the post-performance
ratings of all participants, as well as the pre-performance ratings of the ADHD-
medicated group, tended to be fairly high on the 10-point likert scale. Thus, these
results may be subject to ceiling effects, which could be masking the potential for
ratings to have risen further.
Hypothesis 6
Extending this examination of self-evaluations, analysis of hypothesis six revealed
that children with ADHD and children in the control group did not differ
significantly in the degree to which they attributed their performance to external
factors. As such, participant's perceptions of (a) how easy they thought it had been
to pay attention; (b) how hard they felt they had tried; (c) how lucky they felt they
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had been; and (d) how hard they thought the task was, were comparable across the
control and experimental groups. Furthermore, these perceptions remained
comparable, regardless of whether or not children with ADHD were in the medicated
or unmedicated condition. In addition, irrespective of medication condition, there
was no difference in the degree of importance participants with ADHD attached to
each of the five variables (attention, trying, task difficulty, luck and medication) with
respect to the overall influence they had on performance.
These results fit with the study's earlier finding of comparable locus of control scores
between the experimental and control participants, thus, together, could be
interpreted as evidence that, contrary to popular belief (e.g. Hoza et ah, 1993; Lufi &
Parish-Plass, 1995), children with ADHD are not more likely to attribute their
performance to external factors or to view their experiences as being outwith their
personal control. Indeed, the results of the current study directly replicate some of
the findings of an earlier study by Milich et al. (1989), in which, despite yielding
significantly superior scores on the Continuous Performance Task on medication
compared to placebo, there were no significant differences in the mean self-
evaluations and attribution responses of participants with ADHD across the two
conditions. Furthermore, in the current study, no evidence was found to support
contentions that medication may produce predominantly external or medicated-
related explanations for performance (e.g. Rosen et al., 1985). In fact, in comparison
to the other two, more internal factors considered, participants were less likely to
choose 'medication', Tuck' or 'task difficulty' as being important to their overall
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performance. This pattern was consistent regardless of medication status (see figures
VII & VIII of the Results section).
As mentioned earlier, other researchers have found a difference in the attributions
made by children with ADHD in comparison to those of control children. For
instance, Hoza et al. (2000) reported that boys with ADHD were more likely to
attribute task success to external, uncontrollable factors such as task ease and luck,
while children in the control group were more likely to attribute failure to internal
factors such as not trying hard enough. However, this study assessed participants'
attributions about a social task in which they were required to 'get-acquainted' with
another child. It may be possible that the process of making attributions for our
behaviour varies as a function of whether the task makes social or academic
demands. Given that the task employed in the current study was largely academic-
based, the difference in the nature of the two tasks may provide some explanation for
the discrepancy in results.
Milich et al. (1989), however, went onto report a finding of increased
correspondence between the actual performance and self-evaluations of participants
in the medicated condition, compared to the placebo condition. They interpreted this
as evidence that medication may enhance participants' ability/motivation to monitor
their own behaviour, consequently leading them to develop better task strategies
(Milich et al., 1989). Unfortunately, due to measurement differences in the way that
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actual and self-perceived performance was scored in the current study, it was not
possible to compare the two variables directly. This is a considerable
methodological weakness as such comparisons would have allowed a determination
of the degree of accuracy with which all participant groups were rating their
performance and may have offered further potential for explaining the findings
reported.
Nonetheless, the current results suggest that perceptions of performance in children
with ADHD do not differ from those of control children or across medication status.
As such, these results contradict contentions that medication may lead children with
ADHD to attribute their behaviour to external factors (e.g. the drug) while viewing
their own efforts/abilities as having a relatively minor role (Bugental et al., 1977).
4.2.4 Summary
The study found that, irrespective of medication status, children with and without
ADHD did not differ in respect of the following: their level of inhibitory control,
their locus of control scores, their self-evaluated performance or the attributions
made for their performance. Furthermore, no relationship between locus of control
and inhibitory control was detected. Nonetheless, methylphenidate did significantly
improve the inhibitory control of children with ADHD. It is suggested that these
findings may be the result of a number potential factors including motivational
aspects, the possibility that different tests tap different components of response
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inhibition (Kerns et al., 2001), as well as the potential impact of a positive illusory
bias in children with ADHD. Variations in the types ofmeasures employed, dose and
type of medication received, and cultural differences between study participants are
offered as potential explanations for discrepancies between the current findings and
those of previous research. The next section will examine the methodological
limitations of the study and the extent to which these may have influenced the
results.
4.3 Methodological Considerations
4.3.1 Limitations of the Measures
Estimated Full Scale IQ
Full-scale IQ was estimated using a shortened version of the Wechsler Intelligence
Scale for Children, UK (WISC-III UK, 1991). This was comprised of one verbal
subtest (Vocabulary) and one performance subtest (Block Design), with a Full-Scale
IQ score being estimated using the method described by Sattler (1992). Although the
validity of this short form is high (r = 0.906), a number of methodological problems
question the utility of short-forms (Sattler, 1992). Even those with high validity have
been found to misclassify people and limit the opportunity for profile analysis
(Sattler, 1992). As the current study found no significant group differences in full-
scale IQ estimates, this variable was excluded from analysis. However, it should be
noted that, had the research been subject to fewer constraints, it may have been
useful to assess children's IQ more accurately using the full-version of the scale.
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The Animal Stroop Task
As Schachar and Logan (1990) expressed,
"...no widely accepted measure of inhibition exists" (Schachar & Logan, 1990, pg.
711).
The Animal Stroop was selected on the basis of its recognition as a reliable and valid
measure of inhibitory control (Wright et ah, 2003) and, being pictorial-based, it had
the particular advantage over other Stroop-type measures in that it did not require a
certain level of reading ability in order to yield reliable scores. However, there may
be potential limitations of the Animal Stroop Task with regards to its use in the
current study.
Wright et al. (2003) advocate that the Animal Stroop Task provides a robust measure
of inhibitory function across the age range of three to sixteen years. However, they
do warn that, while the content domain of the task (i.e. animal picture naming) is
sufficiently easy for younger children, it may be a less sensitive measure of impulse
control in older children (Kail, 1991). The authors report that a Stroop-like effect did
remain, even in their 16-year old participants, but do caution that there may be floor
and ceiling limitations on its validity. The participant sample of the current study
comprised children up to the age of 14 years and with this, alongside the researcher's
own observations of increased task ability in older children, it is possible that ceiling
effects amongst the older participants may be masking a difference between the
inhibitory control of participants with and without ADHD.
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Although the measure only took approximately ten minutes to complete, many of the
children, especially those with ADHD, became distracted during the task. As such,
their response times were often quite variable and, in some cases, the number of
omission and response errors was fairly high. This resulted in a smaller number of
valid trials being available for the calculation of inhibitory control, thus reducing the
reliability of these measures for some participants. Nonetheless, given attentional
difficulties are one of the main behavioural features of ADHD, it would have been
useful to examine this more thoroughly, perhaps by looking at whether there were
differences between the number of omission and commission errors accrued in the
different participant groups and experimental conditions. However, due to a lack of
published material regarding the Animal Stroop Task, it was not clear what these
error rates were specifically measuring. As such, it was considered best to exclude
them from further analysis.
Locus of Control
As mentioned, locus of control was measured using the Locus of Control Scale for
Children (LCSC) (Nowicki & Strickland, 1973) for participants aged nine and over,
while the Preschool and Primary Nowicki-Strickland Internal-External Scale
(PPNSIE) (Nowicki & Marshall, 1974) was used for those below nine years of age.
Used together, these scales allowed for a parallel, age-appropriate, reliable and valid
measure of locus of control for children across the age-range of the sample (Nowicki
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& Strickland, 1973; Nowicki & Marshall, 1974). Indeed, the Nowicki-Strickland
scales are considered to be
"...one of the most widely used [scales]" (Furnham & Steele, 1993, pg. 462).
However, rather than classifying people as having an 'external' or 'internal' locus of
control, the scale measures the degree of internality and externality on a continuum.
As such, the nature of the data dictated that only correlational analyses could be
carried out rather than tests of difference.
In addition, some of the recent research has moved away from the internal-external
dichotomy, claiming that a more differentiated view is needed in order to fully
investigate the developmental aspects of control perceptions (Skinner & Connell,
1986). As such, a number of multi-dimensional scales have now been developed.
For instance, Connell (1985) developed the 'Multidimensional Measure of Children's
Perceptions of Control' in which three dimensions of control are independently
assessed; 'internal', 'powerful others', and 'unknown'. Each of these sources of
control is further assessed within three behavioural domains: 'cognitive', 'social',
and 'physical'. Connell (1985) claims that multidimensional measures provide a
richer 'idiographic' representation of children's perceptions of control. It is possible
that by using a multi-dimensional scale, there may have been more opportunity to
assess children's perceptions of control in more depth. However, given the
constraints of the current research, alongside the fact that the majority of these scales
are not suitable for use with younger children, the Nowicki-Strickland Scales
appeared to be the most appropriate tools to employ as a measure of Locus of
Control.
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Self Evaluation and Attribution Questionnaire
Due to a lack of standardised measures relating to the specifics of the tasks
employed, the researcher developed a questionnaire to assess participants' evaluation
and attributions for their performance on the Animal Stroop task. While this
assessment was based on previous research examining attributions (Milich et ah,
1989), the reliability and validity of the measure remains unknown.
In retrospect, a number of features of the questionnaire could have been improved.
While the majority of participants were considered to fully understand all elements
of the questionnaire, some of the younger children appeared to have difficulty with
the concept of rating using a Likert scale. The researcher tried to limit this effect by
using a pictorial representation of the scale - i.e. an illustration of a thermometer
where the temperature gauge increased, by intervals of one, from 0-10 (see
appendix 7.19) - and by explaining the process of rating to the child using
developmentally appropriate language. Despite each child confirming that they
understood, those participants (particularly the younger children) whose
comprehension of what was required seemed less clear, tended to opt for the extreme
point of the scale - i.e. number 10. As such, the rating data may have been subject to
ceiling effects. However, a number of researchers note that, when asked to use
Likert rating scales, younger children seem to respond in an extreme manner (i.e.
selecting the options placed at either end of a response continuum) (e.g. Chambers
& Craig, 1998; Goodenough et al., 1997). This is supported by Piagetian theory
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contending that young children characteristically engage in dichotomous thinking
(Gelman & Baillargeon, 1983). As such, this extreme pattern of responding amongst
the younger participants was, perhaps, unavoidable.
Some of the questions themselves could also have been altered. For instance, basing
it on Milich et al.'s (1989) study, children were asked to rate how easy it had been to
pay attention and to rank how important they felt paying attention had been to their
overall performance on the task. Enquiring about perceptions of attention was
particularly relevant to Milich and colleagues who were assessing a group of boys
with ADHD on the Continuous Performance Task - a test of sustained attention.
Although attentional difficulties are one of the cardinal features ofADHD, given that
the current study aimed to specifically assess inhibitory control, it may have been
more valuable to replace the questions pertaining to attentional ability with ones that
enquired about participants' perceived response inhibition e.g. 'How easy did you
find it to name the animal's body instead of the head?'. Inclusion of this question
may have allowed for more direct investigation of participants' perceptions of their
own inhibitory control.
Participants in the experimental group were asked directly about any effects they felt
their medication may have had on their task performance and some comparison
across the medicated and unmedicated conditions was afforded by including
'medication' as a factor in the list of variables that participants were asked to rank in
order from least to most important. While the importance attached to 'medication'
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remained relatively stable, irrespective of condition, it may have been useful to have
included additional questions to allow more detailed comparisons of the perceived
effects of medication. For instance, in the unmedicated condition, participants were
asked if they felt they would have performed 'better', 'worse' or 'the same' had they
taken their medication as usual. Overall, the majority of participants (52.4%) felt
they would have performed to an equivalent standard after taking medication.
Almost 40% of participants with ADHD believed they would have done better on the
Animal Stroop task had they been able to take their medication, while just under 10%
reported that they would have done worse. However, participants were asked this
question in the unmedicated condition only and, as such, there was no scope for
examining whether these perceptions might have been different had participants
taken their medication. It may, therefore, have been useful to have included a
modified version of this question which could have been posed to participants in the
medicated condition - e.g. 'If you had not had your medicine as normal this morning,
do you think you would have performed 'better', 'worse' or the 'same?'. Similarly,
participants in the medicated condition were asked to rate how much they felt their
medication had helped on a scale of 1-10. Including a corresponding question in the
unmedicated condition (e.g. 'If you had had your medication as normal this morning,
how much do you think it would have helped you with the task?'), would again have
allowed more of a comparison of participant views across conditions.
Lastly, rather than asking participants to give a general rating of their overall
performance out of 10, it may have been more appropriate to ask them to pre- and
post-estimate the number of mistakes they felt they would make/made. This could
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have allowed for a more direct comparison of perceived- vs. actual- performance.
Nonetheless, given the aforementioned concerns about what the error data actually
measures, any such results would have required cautious interpretation.
Despite the flaws highlighted above, the researcher's need to self-design this
questionnaire was necessitated by the lack of standardised measures relating to the
specifics of the task employed. It should also be noted that while, in some respects, a
novel measure, the assessment was essentially based on the questions used in
previous research of a similar nature (i.e. Milich et ah, 1989). Had the current
research not been subject to time constraints (see subsequent discussion), it may have
been beneficial to have conducted a pilot study so that any such weaknesses could
have been detected and modified accordingly. Overall, however, the questionnaire
employed did cover the main areas under investigation and was considered
appropriate for use with the large majority of participants.
4.3.2 Limitations of the Sample Size
The ADHD database contained 98 names of children deemed suitable to take part in
the study, therefore all 98 families were contacted and invited to participate. In order
to achieve statistical power for the between subjects tests of difference, 20
participants were required, while only 12 participants were required for the within
subjects tests of difference (Clark-Carter, 2004) - response rates of 20.41% and
12.24% respectively. With an overall response rate of 25.51%, the required number
of participants was recruited. This remained the case even after 4 experimental
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participants were excluded due to incomplete data, reducing the total number of
experimental participants to 21.
It should be noted, however, that two participants were removed from each of the
ADHD group (medicated condition) and the Control group due to outlier scores on
the inhibitory control measure of the Animal Stroop. While these scores needed to
be removed in order for the groups to be matched on the inhibitory control task, it
meant that in analyses examining inhibitory control, the experimental group
(medicated condition) was reduced to 19 and, as such, did not meet the 20
participants required for the between subjects tests of difference. In these particular
analyses then, the number of participants within the medicated condition of the
experimental group was insufficient to reach statistical power.
4.3.3 Time Constraints
Although the required number of participants was, for the most part, achieved, it may
have been possible to recruit more participants had the study not been affected by the
considerable time constraints on the data collection phase of this study.
For instance, the process of acquiring ethical approval is one which is lengthy and
often time-consuming. Had this not been a factor in delaying data collection, there
may have been more time to recruit additional participants and/or look to extending
the research into another service area, e.g. Lothian.
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A number of other factors may have played a role in the relatively low participant
response rate. Given the link between parents with a chaotic parenting style and
children with ADHD (Johnston & Mash, 2001), it is possible that families may
simply have lost or forgotten to return the forms. While some families were sent the
information on more than one occasion, it was not felt practical or ethical to re-send
the information to all 98 families. People may also have been put off by the direct
testing aspect of the study, with parents and/or children potentially worrying about
the level at which they might perform. It is possible that the requirement for
participants to be seen twice for relatively lengthy sessions was also a factor that
influenced whether people decided to take part. Although attempts were made to
make this process as convenient as possible by offering each participant the option of
where they would prefer to be seen - i.e. school, the unit or, in some cases, at home -
it is possible that the level of commitment these appointments engendered may have
deterred people from taking part. Having to skip a dose of medication is a
component that may have been influential in the recruitment of participants. While
the lack of risk associated with this procedure was detailed in full within the
participant information sheet, with both the researcher and the Child and Adolescent
Psychiatrist being available for consultation throughout, this factor may have been
enough to dissuade people from participating.
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Given the response rate amongst the control group was considerably higher
(73.53%), it is likely that some of the above factors - specific to participants in the
experimental group - were most influential in the process of participant recruitment.
As mentioned previously, had the research not been subject to such time constraints,
it may also have been useful to have conducted a pilot study in order to allow for any
potential weaknesses detected to be modified accordingly.
4.3.4 Design Limitations
ADHD Diagnosis
As mentioned in the introduction, ADHD encompasses three subtypes - 'inattentive',
'hyperactive-impulsive', and 'combined' ADHD (Rappley, 2005). While all
participants in the current study had been given a diagnosis ofADHD by a consultant
psychiatrist or multi-disciplinary team prior to taking part in the study, they had not
been classified as a particular subtype and, as such, the current study did not take into
account the potential influence of different subtypes. This, however, may have been
an interesting factor to include, allowing for investigation of whether the inhibitory
control of participants with ADHD differed depending on their specific subtype of
ADHD. It might be expected that those classed as 'hyperactive-impulsive' or
'combined' types would perform more poorly than those classed as being within the
'inattentive' subtype. Nonetheless, classifying participants with ADHD into the
different subtypes can be problematic in that it is not necessarily as easy to define
children into three clearly distinct subtypes. For instance, children in either the
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inattentive or hyperactive-impulsive subtype may be just one symptom below the
threshold for the combined subtype, thus specific subtypes may be contaminated by
contrasting features of another subtype (vanMourik et al., 2005).
Although children in the experimental group had been given a diagnosis of ADHD,
the study did not make use of any independent diagnostic interview or corroborating
diagnostic information. It may, therefore, have been beneficial for the study to have
included a parent interview, allowing the researcher to gain further information about
the child, e.g. by means of administering the Diagnostic Interview Schedule for
Children (DISC)-IB (Shaffer et al., 2000) - a structured interview that generates
DSM-IV diagnoses. Not only would use of this schedule have allowed the
researcher to ascertain which of the ADHD subtypes each participant came under
and provided the opportunity for these aspects to be explored further, it would have
afforded additional support for the original ADHD diagnosis. Examining the
different subtypes of ADHD with regard to both inhibitory control and to the self-
perceptions of participants with ADHD may present an area for further research.
Children who were diagnosed with any other significant mental health condition (e.g.
autistic spectrum disorder) were excluded from the study, as were children with a
learning disability. This was felt to be an appropriate measure to take in order to
ensure that participants would be able to sufficiently complete the study's
requirements without causing distress. Nonetheless, with an abundance of research
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documenting the high incidence of comorbid disorders in ADHD (Moser & Bober,
2002), it is possible that the current sample may not accurately represent the general
ADHD population. It should be noted, however, that recent research suggests that
comorbid disorders are unlikely to account for the related cognitive difficulties in
children with ADHD (e.g. Niggs et al., 1998).
Inhibitory Control and Behaviour
It would have been interesting to compare the results of the inhibitory control
measure to behavioural data. Using a school-based sample of participants, Wright et
al. (2003) compared participants' behavioural data (collected from teacher-rated
Conners ADHD index (Conners, 1996)) to their scores on the inhibitory control
measure of the Animal Stroop task. Although correlations suggested an absence of a
general relationship between task performance and ratings of behaviour, Wright et al.
(2003) went onto categorise the participants into 'high' and 'low' risk groups
depending on whether they scored above or below the 75th percentile on Conners
ratings of hyperactivity. On the basis of their performance on the Animal Stroop
Task, children were also classified as having either 'good' or 'poor' inhibition.
These more detailed comparisons suggested that children with high hyperactivity or
ADHD ratings performed more poorly on the measure of inhibitory control than
those with low behavioural ratings. In addition, children in the poor inhibition group
were rated as more hyperactive, more oppositional, and as possessing more
symptoms of ADHD than those classed as having good inhibitory control. The
authors interpreted these findings as evidence of an association between poor
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inhibitory control and a range of behavioural symptoms in a non-clinical sample of
hyperactive children.
In view of the promising results of this study, it would have been interesting for the
current study to have compared behavioural data with the inhibitory control scores of
the experimental group to see whether the relationship between behaviour and
inhibitory control was replicated in a clinical sample. However, given the various
constraints of the current research, it was not felt possible to include investigation of
behavioural data. It may, however, be a valuable area for further research to explore.
The 'Skipping a Dose' Strategy
Within the unmedicated condition of the study, children with ADHD were assessed
after not having had any methylphenidate for a period of at least 12 hours.
Considering the short-half life of methylphenidate, 12 hours should be ample time
for any effects of the drug to have died out. However, by using this strategy, all
participants were aware that they had skipped a dose and it may be possible that the
knowledge of not having had medication was enough to generate changes in the
children's behaviour and consequently their level of inhibitory control.
Unfortunately, it was not possible to control for the effects of any such influence
within the study. Rather than directly skipping a dose then, it may have been more
effective to have administered a placebo drug to all participants prior to testing them
in the unmedicated condition. Indeed, other studies have utilised such methods (e.g.
Milich et ah, 1989). However, using a placebo would not have afforded the
assessment of whether there were self-evaluation differences associated with
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participants knowing whether or not they were on medication. Furthermore, there
are ethical concerns over the use of a placebo and, given the participants with ADHD
were all part of a clinical population attending for treatment, using a placebo was not
considered appropriate.
Motivation
Poor response inhibition in children with ADHD is often understood as a
motivational deficit whereby children with the disorder do not apply the level of
effort required to achieve and sustain optimal performance (Oosterlaan et al., 1998).
Within this theory, researchers propose that children with ADHD possess an
exceptionally strong tendency to seek immediate rewards (Douglas, 1989). It was
noted that some of the children in the current study, particularly those with ADHD,
did appear to lose interest in the Animal Stroop task and become quite impatient.
Both participant motivation and appeal of the task may, therefore, have played a role
in the overall results.
The issue of motivation may tie in with the previously mentioned finding that
participant response times were often quite variable. Indeed, the majority of children
with ADHD had at least one trial that the Animal Stroop task guidance highlighted as
comprising 'unreliable reaction times' - suggesting that the variability in the
individual's reaction times is greater than that found in the normative sample
(Wright, 2006, personal contact). In addition, the number of omission and response
errors yielded by some participants was fairly high. While this was also true for
some of the control participants, this pattern of responding was more common in
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participants with ADHD. Indeed, other studies have reported similar findings of
slow, variable and inaccurate responses in children with ADHD (e.g. Kunsti et al.,
2001). This pattern fits with a state-regulation theory of hyperactivity (Van der
Meere, 1996) which argues that the core problem in hyperactivity relates to a non-
optimal state of activation/effort, potentially leading to a lack of consistent effort
(Oosterlaan & Sergeant, 1996).
Indeed, some studies investigating inhibitory control aim to increase motivation for
effort by informing children when they have responded incorrectly and only analyse
the reaction times of trials where responses were correct (e.g. Simpson & Riggs,
2005). Indeed, Douglas & Parry (1983) contend that simple, continuous positive
verbal feedback can reduce the variability of reaction times and decrease mean
reaction times of children with ADHD. Others go as far as to impose a system of
monetary reward and monetary loss (Jennings et al., 1997). As such, providing
participants with feedback or some other form of incentive may have encouraged
children with ADHD to perform at an optimal level and maintained their motivation
to stay focused on the task, as well as reduced the variability of reaction times. In the
present study, however, it is possible that a lack of motivation may have resulted in
children with ADHD performing more poorly than they might otherwise have done.
Given the study was also examining participants' self-perceptions of their
performance, it was felt that providing such comment, may influence the responses
given on the attribution questionnaire and may, consequently, effect their legitimacy
as participant perceptions. Further research is needed in order to decipher the degree
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to which the activation/effort state of children with ADHD influences their capacity
for inhibitory control.
The Effect of Behavioural Treatment Programmes
There is limited research examining the effects of behavioural treatment programmes
on the attributions made by children with ADHD. However, it has been shown that
self-control plus attributional training for children with ADHD improved their
academic and classroom performance, as well as their attributions of personal control
(Reid & Borkowski, 1987). Parental attributions for a child's behaviour can also
change as a result of behavioural treatment (Johnston & Leung, 2001). Johnston and
Leung (2001) found that, with behavioural management, parents viewed the
compliance of children with ADHD as being more external and stable, while non¬
compliance was seen as more controllable but less stable. The current study did not
control for whether participants had ever undergone any form of behavioural
treatment. As such, it may be possible that other interventions may have had an
effect on participants' locus of control and/or the attributions made.
4.4 Clinical and Ethical Implications
A major clinical implication of the current study is that it raises awareness of the
need to monitor the effects ofmedication treatments on response inhibition. Whether
medication is improving a child's ability to control their inhibition is an important
area as such improvements may aid them in other areas of development, such as
attentional ability, social skills etc. Indeed, Tannock et al. (1989) found that, in
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children with ADHD, improvements in behaviour and academic performance
resulting from treatment with methylphenidate were strongly associated with
improvements in inhibitory control, as measured by the stop-signal paradigm.
Conversely, monitoring the symptoms ofADHD is also important when we consider
the abundance of negative consequences that can develop from the disorder, such as
conduct disorder (Taylor et al., 1996). In particular, considering research linking
inhibitory control to psychopathology by focusing on the impulsive component of
ADHD (Schachar et al., 1993), the monitoring of inhibitory control in relation to
applying interventions to help counter such difficulties, may be especially important.
In clinical practice, the effects ofmedication on children with ADHD are monitored
in relation to their effects on observed behaviour. These observations, however, can
be fairly subjective. Utilising a variety ofmeasures is important as improvements in
response inhibition may not be evident through behavioural observations. Although
producing no changes in perceptible behaviour, it is possible that increased inhibitory
control may be having more subtle effects that might influence a child's academic
ability - a feature more clearly detected by neuropsychological testing. The results
of this study highlight the effectiveness of involving neuropsychological tests in
monitoring the potential effects of medication on response inhibition. By providing
an indication of whether medication would be effective, such tools could also
provide useful information to be included in the consideration of whether a child
should be given a trial of medication. Thus, being readily available and easy-to-
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administer, clinicians should recognise the value of using neuropsychological tests,
such as the Animal Stroop, more widely in clinical practice.
The lack of significant difference between the inhibitory control of children with
ADHD (irrespective of medication status) and children in the control group was also
an important finding, which calls question over Wright et al.'s (2003) original
suggestion of using the Animal Stroop task as a potential screening measure to
identify children at risk of hyperactive symptomatology.
In addition to the clinical implications of this research, the study also raised some
ethical issues for consideration. For instance, the finding that children with ADHD
demonstrated superior inhibitory control whilst on medication, not only in
comparison to their performance off medication but in comparison to that of
participants in the control group3, suggests that methylphenidate may actually elevate
children's capacity for inhibitory control to an above-average level. As such, the
finding highlights ethical concern over the potential for medication to be used as a
method of enhancing behaviour in children with ADHD to an extent that is beyond
that typical of normally developing children. Given that the behaviour of normally
developing children can also be improved by stimulant medication (Rapoport &
Inoff-Germain, 2002), this matter could prove to provoke considerable concern.
J It should be noted that the difference between inhibitory control between children with ADHD and
children in the control group did not reach statistical significance.
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Nonetheless, the finding that the self-perceptions and attributions made by children
with ADHD did not vary as a function of their medication status, does ameliorate
previous concerns that medication may lead children with ADHD to attribute their
behaviour to external factors (e.g. the drug) while viewing their own efforts/abilities
as having a relatively minor role (Bugental et al., 1977), and diminishes notions of
them subsequently becoming reliant on drugs to focus their attention and effort
(Rosen et al., 1985).
4.5 Future Research
Despite the methodological constraints of the current study, in addition to the
aforementioned avenues for research already discussed above, the study highlighted
a number of other areas which may require further research.
Firstly, the lack of a significant difference between the inhibitory control of
participants with and without ADHD was unexpected and one which requires further
investigation. Given the current research was the first known study to make use of
the Animal Stroop as a measure of inhibitory control with a clinical group of children
diagnosed with ADHD, it would be useful to see whether these findings are
replicated. In addition, it would be interesting to see how the performance of
children with ADHD on the Animal Stroop compares to their performance both on
the original, widely-used, Colour-Word Stroop task, as well as to other tests of
response inhibition. Such comparisons may aid further exploration of the notion that
different tests tap distinct components of response inhibition (Kerns et al., 2001).
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Due to the restraints of this research, it was not felt possible to examine any
additional relationships between gender and/or age on response inhibition,
medication effects and/or attributions for performance. Given the incidence of
ADHD is significantly higher in boys (outnumbering the incidence in girls by
between 4:1 (Gaub & Carlson, 1997) and 3:1 (Barkley, 1997)), it is not surprising
that previous research on ADHD tends to focus on male participants. While studies
involving girls with ADHD tend to report that there are no effects of gender on
response inhibition (e.g. Daugherty et al., 1993; Kunsti et al., 2001), given the
limited amount of research encompassing female participants, it would have been
useful to re-examine these contentions within the current sample. Furthermore,
exploration of whether gender had any influence over the effects of medication
and/or the attributions made by participants may also have been interesting.
Despite inhibitory control in normally-developing individuals being shown to
improve throughout childhood (Williams et al., 1999; Wright et al., 2003), this
relationship is non-linear - the most rapid improvements in inhibitory control being
between the ages of 3 1/2-5 years (Simpson & Riggs, 2005). There is little research
examining the development of this ability in children with ADHD, however,
Jennings et al. (1997) reported that, while 10-12 year-old boys with ADHD showed
better response inhibition than their 8-10 year-old counterparts, there was no such
improvement in a group of control boys. It may well be possible then that, in regards
to inhibitory control, children with and without ADHD experience different
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developmental trajectories. If children with ADHD are, indeed, slower in their
ability to develop such skills, this may help account for some of the other difficulties
inherent within the disorder. Further exploration of the relationship between age and
response inhibition in children with ADHD would confirm whether this is a
possibility.
In addition, Milich et al. (1989) found that children's attributions vary as a function
of age - older boys being less likely to attribute success to medication and more to
ability. It would, therefore, have been interesting to examine whether the age of
participants in the current study had any effect on the attributions they made.
Factoring in the potential influence that age may have on the effects of medication, in
relation to both inhibitory control and behavioural attributions, is also an area that
may warrant further investigation.
While this study looked at participants' own attributions for their behaviour, it did
not examine the perceptions of others. This is clearly an important avenue to explore
as parents are more likely to respond negatively to misbehaviour if they view their
child as being responsible (Johnston & Patenaude, 1994). Johnston and Leung
(2001) reported that while parents attributed less control to positive behaviours while
the child was on medication, medication increased attributions of control when the
behaviour was negative. The authors interpreted their findings as evidence that
medication treatments could be altering attributions in a way that might, potentially
lead to less positive parental responses to appropriate behaviour (Johnston & Leung,
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2001). Studies examining parental attributions, however, tend to look at these factors
in relation to social behaviour, thus, while the attributions made by participants in the
current study did not differ between medication conditions, it may be useful to
extend these investigations. Examining the effects that medication may have on the
attributions made, both by parents and by teachers, in relation to children with
ADHD's performance on more academic-based tasks, would allow us to determine
whether the pattern detected by Johnston & Leung (2001) holds true with regards to
non-social behaviours.
Lastly, as previously discussed, Barkley (1997) contends that other deficits seen in
ADHD, such as working memory, self-regulation etc., result from a central
impairment in response inhibition. Given the current improvements medication
appears to have on the inhibitory control of children with ADHD, it would be
interesting to further explore the relationships between inhibitory control and other
known-deficits in ADHD in relation to the effects of medication.
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5. Conclusion
The present research used a newly developed measure - the Animal Stroop Task
(Wright et ah, 2003) - to examine whether methylphenidate-based medication is
effective in improving inhibitory control in children with ADHD. In addition, the
study looked at children's own attributions for their level of response inhibition
across a variety of variables, including medication status. Although subject to
methodological limitations outlined above, the study found that methylphenidate did,
indeed, improve the inhibitory control of children with ADHD. This fits with
previous reports of methylphenidate ameliorating deficits in response inhibition as
measured by other tests of inhibitory control (Broyd et al., 2005, Everett et al., 1991),
as well as reported improvements in other areas of difficulty (Pelham et al., 1986;
Miller et al., 1998; Hood et al., 2005; Kempton et al., 1999). However, despite this
improvement, the study did not detect any significant differences between the
inhibitory control of children with ADHD (irrespective of medication status) and
children in the control group. This is in contrast to a considerable amount of
evidence documenting deficits in the inhibitory control of children with ADHD, and
challenges the well-established theory that poor response inhibition is the cardinal
feature of ADHD (Barkley, 1997). This lack of difference, however, may provide
support for contentions that different tasks tap different components of inhibition and
that not all levels of inhibition are necessarily impaired in children with ADHD
(Kerns et al., 2001). Alternatively, it may offer support for the 'delay aversion'
hypothesis in which cognitive deficits in children with ADHD are thought to be more
motivational in nature (Sonuga-Barke et al., 1996). There was no difference between
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the locus of control of children with and without ADHD, and locus of control was
found not to be related to inhibitory control. Additionally, children with and without
ADHD did not differ in the degree to which they attributed their performance to
external factors and perceptions for behaviour remained comparable, regardless of
whether or not children with ADHD had received medication. Thus, contrary to
popular belief (e.g. Hoza et ah, 1993; Parish-Plass, 1995), children with ADHD did
not appear more likely to attribute their performance to external factors or to view
their experiences as being outwith their personal control. Furthermore, the results
are consistent with other studies that generally fail to find any deleterious effects of
medication with regards to children's attributions for their behaviour (e.g. Carlson et
ah, 1993); Milich et ah, 1989). The thesis identified a number of areas for future
research, including further exploration of the links between medication, response
inhibition and behaviour, in relation to the potential influence that age and gender
may have on these relationships. Children with ADHD face a number of difficulties,
many of which may improve with drug-treatment. While the Animal Stroop Task
may not be effective in differentiating between children with a clinical diagnosis of
ADHD and normally developing children, it may provide an additional tool to
monitor the effects ofmedication-based treatments such as methylphenidate.
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7.1 Appendix: Diagnostic Criteria for ADHD
Diagnostic Criteria for Attention Hyperactivity Disorder in DSM-IV
(American Psychiatric Association, 1994)
Either 1 or 2:
1. Six or more of the following symptoms of inattention have persisted for at
least 6 months to a degree that is maladaptive and inconsistent with
developmental level.
Inattention:
• often fails to give close attention to details or makes careless mistakes in school
work, work or other activities
• often has difficulty sustaining attention in tasks or play activities
• often does not seem to listen when spoken to directly
• often does not follow through on instructions and fails to finish school work,
chores or work duties
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• often has difficulty organising tasks and activities
• often avoids or dislikes tasks that require sustained mental effort
• often loses things necessary for tasks or activities
• is often easily distracted by extraneous stimuli
• is often forgetful in daily activities
2. Six or more of the following symptoms of hyperactivity-impulsivity have
persisted for at least 6 months to a degree that is maladaptive and inconsistent
with developmental level.
Hyperactivity:
• often fidgets with hands or feet or squirms in seat
• often leaves seat in classroom or in other situations in which remaining seated is
expected
• often runs about or climbs excessively in situations in which it is inappropriate
• often has difficulty playing or engaging in leisure activities quietly
• is often on the go or acts as if driven by a motor
• often talks excessively
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Impulsivity:
• often blurts out answer before questions have been completed
• often has difficulty awaiting turn
• often interrupts or intrudes on others
Some of these symptoms were present before the age of 7 years
Some impairment from the symptoms is present in two or more settings (e.g. home
and school)
Clinically significant impairment in social, academic or occupational functioning
Not due to another disorder
Specify combined type if inattention and overactivity-impulsivity are present;
inattentive type if overactivity is absent; hyperactive-impulsive type if inattentiveness
is absent.
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Diagnostic Criteria for Attention Hyperactivity Disorder in ICD-10
(World Health Organisation, 1992)
The cardinal features are impaired attention and overactivity. Both are necessary for
the diagnosis and should be evident in more than one situation (e.g. home and
school). Impaired attention is manifested by prematurely breaking off from tasks
and leaving activities unfinished.
The children change frequently from one activity to another, seemingly losing
interest in one task because they become diverted to another. These deficits in
persistence and attention should be diagnosed only if they are excessive for the
child's age and IQ. Overactivity implies excessive restlessness, especially in
situations requiring relative calm. It may, depending upon the situation, involve the
child running and jumping around, getting up from a seat when he or she was
supposed to remain seated, excessive talkativeness and noisiness, or fidgeting and
wriggling. The standard for judgement should be that the activity is excessive in the
context ofwhat is expected in the situation and by comparison with other children of
the same age and IQ. This behavioural feature is most evident in structured,
organised situations that require a high degree of behavioural self-control
The characteristic behaviour problems should be of early onset (before the age of 6
years) and long duration
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Associated features include disinhibition in social relationships, recklessness in
situations involving some danger, impulsive flouting of social rules, learning
disorders, and motor clumsiness
Specify hyperkinetic disorder with disturbance ofactivity and attention when
antisocial features of conduct disorder are absent; hyperkinetic conduct disorder
when criteria for both conduct disorder and hyperkinetic disorder are met
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We are conducting a research project looking at response inhibition in children with
Attention Deficit Hyperactivity Disorder (ADHD).
I would like to invite your child to participate in the project.
I have enclosed some information to help you decide whether or not you would like your
child to take part. I have also enclosed some information for your child. If they have any
problems reading it, please read it aloud to him/her.
If you decide to participate, please sign the enclosed consent forms and return them in the
enclosed SAE. My contact details are also enclosed; please do not hesitate to contact me
with any questions or queries. You are not in any way obliged to take part in this project and
can withdraw at any time without giving a reason.





7.4 Appendix: Parent Information Sheet
7.4.1 Experimental Group
Parent/Guardian Information Sheet
I am conducting a study as part ofmy qualification in clinical psychology, working with
children with and without a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD),
to look more closely at their actual- and self- perceived level of response inhibition.
The title of the project is: An examination of the effects ofstimulant medication on actual-
and self- perceived response inhibition: A comparison between children with and without
attention deficit hyperactivity disorder.
What is response inhibition?
Response inhibition refers to the human skill which allows us to prevent ourselves from
doing things automatically, or avoid the usual routine action, e.g. response inhibition allows
us to be polite when we are given an unwanted present.
Most children develop the ability to inhibit their responses and learn to control their actions
as they get older. However, some continue to have difficulties with such skills, leading them
to act without thinking, blurt out comments inappropriately and/or appear overactive and
distractible. Amongst other symptoms, this kind of behaviour is often characteristic of
children with ADHD.
Your child is being invited to take part in this research study. Before you decide whether or
not you would like them to take part, it is important for you to understand why the research
is being carried out and what it will involve. Please take the time to read the following
information carefully and discuss it with others if you wish. Please contact me if there is
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anything that is not clear or if you would like further information. Thank you for reading
this.
Why has my child been chosen?
I am inviting children with a diagnosis ofADHD and children without a diagnosis. I am
inviting children without a diagnosis, as a control group, so I can compare the two groups
and see if there are any differences.
What is the purpose of the study?
The aim of the study is to look at children's actual and self-perceived levels of response
inhibition. I would like to compare children who have ADHD and children who do not. I
would also like to see whether medication has a direct effect on such abilities in children
with ADHD. Currently, the research in this area has produced unclear results.
What does the study involve?
Your child will be asked to complete a brief test of intelligence (involves creating patterns
with a series of blocks and then giving the meanings of numerous everyday words), a
computerised test of response inhibition (children are asked to look at pictures where the
head of one of four animals has been swapped with another animal. The child is asked to
give the name for the "body" of the animal, thus having to inhibit the more prominent
response based on the face). Your child will then be asked to complete a short questionnaire
and asked a few additional questions about how they felt they got on in the computer task.
This will take approximately 60 minutes in total. These will be carried out wherever is most
convenient for you: in school or at the Andrew Lang Unit in Selkirk. In some cases, it may
be possible to visit your child at home. If this is preferable, please feel free to contact the
researcher directly or to indicate this on the consent form.
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Following this session, I will arrange to meet with your child for a second time. During this
session, your child will be asked to complete the same computerised task and the same series
of questions. This will be a shorter session taking only 30-40 minutes.
On one of these two occasions, you will be asked not to give your child their usual ADHD
medication before meeting with me. Missing this one dose ofmedication will not be
harmful to your child and they will be able to take their medication soon after completing the
assessment. If you are concerned about this possibility, please do contact the Andrew Lang
Unit to discuss this with either myself or Dr (Child & Adolescent Psychiatrist).
Your GP will also be notified about your child's participation in the study as a routine
measure.
Will I find out how it went?
If you wish to hear about the results of the study, you can request a written or verbal
summary of the results.
Do I have to take part?
You do not have to take part. Even ifyou sign the consent form, you can withdraw at any
time without giving a reason. Your child will be told at the start of testing, and reminded
throughout testing, that they can leave at any time without giving a reason. A decision to
withdraw, or a decision not to take part, will not affect the standard of care you or your child
receive.
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Will there be any disadvantages?
Although unlikely, should your child become unhappy during the study, the testing will be
stopped immediately. Your child will be asked throughout the study if they are happy to
continue and they will be reminded that they can leave at any time without giving a reason.
What about confidentiality?
All of the information in the study is confidential. The study is designed to promote
knowledge about ADHD, but may be of no direct benefit to you and your child.
If you have no objections to your child's participation in this project, please sign the
enclosed consent form and return it in the SAE provided.
What should I do if I want my child to take part?
If you decide that you would like your child to take part, then please sign the consent form
and send it back in the envelope provided. I will then be in touch via mail or telephone to
arrange the details of where you would like me to see your child, either at school or at the
Andrew Lang Unit in Selkirk. In some cases, it may be possible to visit your child at home.
If this is preferable, please feel free to contact the researcher directly or to indicate this on
the consent form. I will arrange the session times in collaboration with yourselves and also
answer any questions you might have.
Thank you for taking the time to consider taking part in this study. If you have any questions
or wish to discuss any aspects of the study, please do not hesitate to contact me. My contact







I am conducting a study as part of my qualification in clinical psychology, working with
children with and without a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD),
to look more closely at their actual- and self-perceived level of response inhibition.
The title of the project is: An examination of the effects ofstimulant medication on actual-
and self- perceived response inhibition: A comparison between children with and without
attention deficit hyperactivity disorder.
What is response inhibition?
Response inhibition refers to the human skill which allows us to prevent ourselves from
doing things automatically, or avoid the usual routine action, e.g. response inhibition allows
us to be polite when we're given an unwanted present.
Most children develop the ability to inhibit their responses and learn to control their actions
as they get older. However, some continue to have difficulties with such skills, leading them
to act without thinking, blurt out comments inappropriately and/or appear overactive and
distractible. Amongst other symptoms, this kind of behaviour is often characteristic of
children with ADHD.
Your child is being invited to take part in this research study. Before you decide whether or
not you would like them to take part, it is important for you to understand why the research
is being carried out and what it will involve. Please take the time to read the following
information carefully and discuss it with others if you wish. Please contact me if there is
anything that is not clear or if you would like further information. Thank you for reading
this.
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Why has my child been chosen?
I am inviting children with a diagnosis ofADHD and children without a diagnosis. I am
inviting children without a diagnosis, as a control group, so I can compare the two groups
and see if there are any differences.
What is the purpose of the study?
The aim of the study is to look at children's actual and self-perceived levels of response
inhibition. I would like to compare children who have ADHD and children who do not. I
would also like to see whether medication has a direct effect on such abilities in children
with ADHD. Currently, the research in this area has produced unclear results.
What does the study involve?
Your child will be asked to complete a brief test of intelligence (involves creating patterns
with a series of blocks and then giving the meanings of numerous everyday words), a
computerised test of response inhibition (children are asked to look at pictures where the
head of one of four animals has been swapped with another animal. The child is asked to
give the name for the "body" of the animal, thus having to inhibit the more prominent
response based on the face). Your child will then be asked to complete a short questionnaire
and asked a few additional questions about how they felt they got on in the computer task.
This will take approximately 60 minutes in total. These will be carried out wherever is most
convenient for you: in school or at the Andrew Lang Unit in Selkirk. In some cases, it may
be possible to visit your child at home. If this is preferable, please feel free to contact the
researcher directly or to indicate this on the consent form.
Will I find out how it went?
If you wish to hear about the results of the study, you can request a written or verbal
summary of the results.
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Do I have to take part?
You do not have to take part. Even if you sign the consent form, you can withdraw at any
time without giving a reason. Your child will be told at the start of testing, and reminded
throughout testing, that they can leave at any time without giving a reason. A decision to
withdraw, or a decision not to take part, will not affect the standard of care you or your child
receive.
Will there be any disadvantages?
Although unlikely, should your child become unhappy during the study, the testing will be
stopped immediately. Your child will be asked throughout the study if they are happy to
continue and they will be reminded that they can leave at any time without giving a reason.
What about confidentiality?
All of the information in the study is confidential. The study is designed to promote
knowledge about ADHD, but may be of no direct benefit to you and your child.
If you have no objections to your child's participation in this project, please sign the
enclosed consent form and return it in the SAE provided.
What should I do if I want my child to take part?
If you decide that you would like your child to take part, then please sign the consent form
and send it back in the envelope provided. I will then be in touch via mail or telephone to
arrange the details of where you would like me to see your child, either at school or at the
Andrew Lang Unit in Selkirk. In some cases, it may be possible to visit your child at home.
If this is preferable, please feel free to contact the researcher directly or to indicate this on
the consent form. I will arrange the session time in collaboration with yourselves and also
answer any questions you might have.
Thank you for taking the time to consider taking part in this study. If you have any questions
or wish to discuss any aspects of the study, please do not hesitate to contact me. My contact






7.5 Appendix: Child Information Sheet
7.5.1 Experimental Group
Information Sheet for Children
Would you like to take part in a project we are doing at the moment? Please
read this sheet or ask someone to read it to you, to help you make up your mind.
I would like to meet with you to do some puzzles, some computer games and to
ask you some questions. This will take about 1 hour. After that I would like you
to come back another time to try the computer game again. This time we will
only meet for about 30-40 minutes. One of these times, you will be asked not
to take your medication before meeting with me. The person who looks after
you will tell you when not to take your medicine.
All the information gathered will be private.
You don't have to take part if you don't want to.
If you would like to take part, but then change your mind later, that's okay. No
one will mind.
195
Your parent(s)/guardian(s) have been told about the project and you can talk to
them about it. If you would like to talk to me before you make up your mind, we





Information Sheet for Children
Would you like to take part in a project we are doing at the moment? Please
read this sheet or ask someone to read it to you, to help you make up your mind.
I would like to meet with you to do some puzzles, some computer games and to
ask you some questions. This will take about 1 hour.
All the information gathered will be private.
You don't have to take part if you don't want to.
If you would like to take part, but then change your mind later, that's okay. No
one will mind.
Your parent(s)/guardian(s) have been told about the project and you can talk to
them about it. If you would like to talk to me before you make up your mind, we




7.6 Appendix: Parent Consent Form
CONSENT FORM
CONSENT BY PARENT/GUARDIAN FOR THEIR CHILD TO PARTICIPATE
IN:
Title: -
An examination of the effects of stimulant medication on actual- and self- perceived
response inhibition: A comparison between children with and without attention
deficit hyperactivity disorder.
Researcher: -









I confirm that I have read and understood the information sheet for the above study
and have had the opportunity to contact Rachel Brackenridge, Trainee Clinical
Psychologist, to ask questions.
I have agreed to my child taking part in the study as it has been outlined to me.
I understand that these assessments are part of a research project designed to promote
knowledge regarding ADHD, which has been approved by the Borders NHS Ethics
Committee, and may be of no benefit to me personally.
I understand that my child's participation is voluntary and that I am free to withdraw
my child at any time, without giving a reason, without my child's medical care being
affected.
I hereby fully and freely consent to my child participating in the study, which is





I wish my child to be seen (please tick box)
At school
At the Andrew Lang Unit
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7.7 Appendix: Child Consent Form
CONSENT FORM FOR CHILDREN
(Please circle your answer)
Have you read the project information sheet or had someone read it to
you?
Yes No
Have you been able to ask questions about the project?
Yes No
Do you understand that you don't have to take part in the project if you
don't want to?
Yes No
Do you understand that even if you say yes now, you can change your
mind at any time and you don't have to give a reason?
Yes No










7.8 Appendix: Animal Stroop Task Instructions
Task Instructions
An introductory picture of a hot air balloon appears. Explain:
IfI askedyou to name this picture, you'd say... (wait for the child to respond), then say...
That's right, balloon/hot air balloon
Nowyou'll see some morepictures and I'd likeyou to name each picture as quickly as you
can without making too many mistakes.
Press space bar to continue
6 warm-up pictures are shown to get kids used to responding as quickly as they can.
You are now going to see some pictures. I would likeyou to tellme the names ofthese
pictures as quickly as possible.
Can you name the animals on this cardfor me? (show card of 4 animals).
Run through these animal names twice.
Incongruent Blocks
(Cat's head on horse's body)
You're about to see some strange pictures where the animal's head is different to its body.
Sometimes the animal will be wearing a different animal's head like this one, and
sometimes it will have a cartoon facefor a head. Yourjob is to name the animal's body as
quickly as you can.
Now can you name the body ofthisfunny animal?
If children give the correct answer, they should be allowed to proceed with the test.
Incorrect answers should be followed by more direct prompts such as,
202
I wantyou to name the body of thefunny animal
Followed by further repetition of the instructions before proceeding with the test.
Matching Blocks
You're about to see some pictures ofanimals on the screen. I'd likeyou to name the
animal as quickly asyou can after it appears.
Incongruent Blocks
(Cat's head on horse's body)
You're about to see some more strangepictures where the animal's head is different to its
body. Sometimes the animal will be wearing a different animal's head like this one, and
sometimes it will have a cartoon facefor a head. Yourjob is to name the animal's body as
quickly as you can.
Now can you name the body ofthisfunny animal?
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7.9 Appendix: Animal Stroop Scoring Sheet
Kama Jiloaxsia:
Stroop vsrsioa: WCXD ANIMAL Dais
AB AB AB

























Ra; = ?j»n>Dc.ss. W = Mamil ~.nnng «cror. VK = Vac:« 3so»:coa «rrcr. A^ = ArCraJwoa strcc
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7.10 Appendix: Self-Evaluation and Attribution Questionnaire
7.10.1 Experimental Group
Attribution Measure
Before Animal Stroop Test:
Do you think you 7/ do a good or badjob on the Animal Stroop Task?
Good Bad
How many do you thinkyou'll get correct? (mark out of 10)
Following completion of the Animal Stroop Task:
Didyou do a good or badjob on the task?
Good Bad
How many do you think you got correct? (mark out of10)
Participants will then be asked to rate (using a scale from 0-10) the degree to which
each of five attribution categories was responsible for his/her success/failure:
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How easy was it to pay attention?
1 23456789 10
Not at all easy Quite easy Very Easy
How hard did you try?
1 23456789 10
Not at all hard Quite hard Very hard
How hard did you think the task was?
1 23456789 10
Not at all hard Quite hard Very hard
How lucky were you?
123456789 10
Not at all lucky Quite lucky Very lucky
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Group 1 participants in the 'medicated' condition will be asked an additional
question:
How much do you thinkyour medication helpedyou on the computer task?
1 23456789 10
Not at all helpful Quite helpful Very helpful
Lastly, participants will then be asked to rank these five factors in order from most to
least important.
Rank Importance ofthesefactors:




Medicine 5 - least important
How do you think you would have got on with the task ifyou'd taken your
medicine as usual?




Before Animal Stroop Test:
Do you thinkyou'll do a good or badjob on the Animal Stroop Task?
Good Bad
How many do you thinkyou'll get correct? (mark out of 10)
Following completion of the Animal Stroop Task:
Didyou do a good or badjob on the task?
Good Bad
How many do you thinkyou got correct? (mark out of10)
Participants will then be asked to rate (using a scale from 0-10) the degree to which
each of four attribution categories was responsible for his/her success/failure:
How easy was it to pay attention?
1 23456789 10
Not at all easy Quite easy Very Easy
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How hard did you try?
1 23456789 10
Not at all hard Quite hard Very hard
How hard did you think the task was?
1 23456789 10
Not at all hard Quite hard Very hard
How lucky were you?
1 23456789 10
Not at all lucky Quite lucky Very lucky
Lastly, participants will then be asked to rank these four factors in order from most to
least important.
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1 - most important
2
3
4 - least important
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Following our telephone discussion, I write to confirm the times that 1 will be meeting with
AB at the Unit
My first appointment with AB is:
Friday 4th August at 9.30am
On this occasion AB should not take his morning dose of medication. I would be grateful if
you could give AB the attached slip to bring to me on the morning of the 4th ofAugust so I
can confirm that he has not had any medication.
I will be finished meeting with AB by approximately 10am and he will be able to take his
morning dose of medication then. He should return to his usual medication routine the
following day.
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My second appointment to see AB at the Unit is:
Friday 11th August at 9.30am
AB should take all medication as normal on this day.
I hope this is acceptable to you. Ifyou have any queries please do not hesitate to contact me





TO BE RETURNED TO RACHEL BRACKENRIDGE
Name: AB
Date: Friday 4th August 2006
I can confirm that the above named child has not taken their routine morning











My name is Rachel Brackenridge and I am a Trainee Clinical Psychologist currently on
placement at the Unit. In conjunction with the Borders ADHD Team and Child
and Family Mental Health Service, I am currently undertaking a doctorate thesis research
entitled: An examination ofthe effects ofstimulant medication on actual- and self- perceived
response inhibition: A comparison between children with and without attention deficit
hyperactivity disorder.
I am writing to inform you that one of your patients,
(DOB: ), has agreed to participate in the study. As such he/she will be required to
miss a single dose of his/her stimulant medication prior to meeting with me. Due to the
relatively short half-life of this medication, we do not anticipate any adverse effects from this
and will be able to take his/her medication shortly after completing the
test session. Naturally both and his/her parents/guardians have consented to
this aspect of the study and both myself and Dr are available for
consultation throughout the duration of the study. I enclose a copy of the participant
information sheet for your interest.















I just wanted to write and say thank you very much for taking part in my study. You
did very well in all the tasks that we did and I really appreciate your help.
I plan to have finished my study (Entitled: An examination of the effects ofstimulant
medication on actual- and self- perceived response inhibition: A comparison
between children with and without attention deficit hyperactivity disorder) by
February 2007 and I am more than happy to let you and your parents/guardians read
a summary of the results. If you would like to do this, please do not hesitate to
contact me at the Unit.





7.14 Appendix: Distribution of the Variables - Skewness and Kurtosis
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Appendix 7.14
Descriptives - Experiemental Group
Descriptive Statistics - Experimental Group
N Minimum Maximum Mean
Statistic Statistic Statistic Statistic
AGE 21 6.00 14.00 9.3333
FSIQ 21 62.00 • 144.00 94.2857
Locus of Control 21 22.50 67.50 46.7390
RT-med. 1ncongruent 21 676.00 1832.00 1139.6667
RT-med.Matching 21 662.00 1536.00 918.0476
RT-med.Control 21 636.00 1826.00 1102.2857
RT.Difference-med 21 -190.00 216.00 37.3810
Error-med.total 21 .00 15.00 3.1429
omissions-med.total 21 .00 25.00 2.0476
RT-unmed.lncongrue
nt 21 792.00 1770.00 1251.7619
RT-unmed.Matching 21 599.00 1825.00 1064.3810
RT-unmed.Control 21 701.00 1836.00 1147.9048
RT.Difference-unmed 21 -66.00 298.00 103.8571
Error-unmed.total 21 .00 14.00 3.4762
Omissions-unmed.tot
al 21 .00 16.00 2.6667
Valid N (listwise) 21
Descriptive Statistics - Experimental Group
Std. Skewness Kurtosis
Statistic Statistic Std. Error Statistic Std. Error
AGE 2.57553 .290 .501 -1.153 .972
FSIQ 18.16079 .829 .501 1.678 .972
Locus of Control 11.93634 .112 .501 -.654 .972
RT-med. 1ncongruent 301.54027 .801 .501 .277 .972
RT-med.Matching 258.27340 1.358 .501 1.231 .972
RT-med.Control 312.77886 .839 .501 .229 .972
RT.Difference-med 85.30679 -.436 .501 1.754 .972
Error-med.total 3.38062 2.379 .501 7.119 .972
omissions-med.total 5.81787 3.560 .501 13.249 .972
RT-unmed.lncongrue
nt 285.68460 .062 .501 -.922 .972
RT-unmed.Matching 290.12264 .785 .501 1.065 .972
RT-unmed.Control 283.19550 .594 .501 .246 .972
RT.Difference-unmed 103.01616 .391 .501 -.345 .972
Error-unmed.total 3.84212 1.900 .501 3.164 .972
Omissions-unmed.tot




Descriptive Statistics - Attribution Questionnaire Responses - Experimental Group
N Minimum Maximum Mean
Statistic Statistic' Statistic Statistic
Rate.Before-med 21 5.00 10.00 8.8571
Rate.After-med 21 5.00 10.00 8.8571
Attention-med 21 2.00 10.00 8.1905
Trying-med 21 6.00 10.00 8.9524
Task.Difficulty-med 21 1.00 9.00 3.0476
Luck-med 21 1.00 10.00 8.0476
Attention. Rank-med 21 1.00 5.00 2.3333
Try.Rank-med 21 1.00 5.00 2.4762
Difficulty.Rank-med 21 1.00 5.00 3.7619
Luck.Rank-med 21 1.00 5.00 3.5714
Medication.Rank-med 21 1.00 5.00 2.7143
Medication.Help 21 1.00 10.00 7.0952
If.Medication.Taken 21 .00 2.00 1.2857
RateBefore-unmed 21 .00 10.00 7.1905
RateAfter-unmed 21 6.00 10.00 9.1429
Attention-unmed 21 2.00 10.00 6.9524
Trying-unmed 21 3.00 10.00 8.4286
TaskDifficulty-unmed 21 1.00 10.00 3.5238
Luck-unmed 21 1.00 10.00 6.7143
Attention.Rank-unmed 21 1.00 4.00 2.0476
Try.Rank-unmed 21 1.00 5.00 2.0952
Difficulty.Rank-unmed 21 1.00 5.00 3.6667
Luck.Rank-unmed 21 2.00 5.00 3.8571
Medication.Rank-unmed 21 1.00 5.00 3.3333
Valid N (listwise) 21
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Appendix 7.14
Descriptive Statistics - Attribution Questionnaire Responses - Experimental Group
Std. Skewness Kurtosis
Statistic Statistic Std. Error Statistic Std. Error
Rate.Before-med 1.49284 -1.227 .501 .861 .972
Rate.After-med 1.79682 -1.536 .501 1.007 .972
Attention-med 2.46209 -1.509 .501 1.318 .972
Trying-med 1.56449 -1.126 .501 -.425 .972
Task.Difficulty-med 2.78345 1.330 .501 .468 .972
Luck-med 2.57830 -1.451 .501 1.665 .972
Attention.Rank-med 1.35401 .792 .501 -.557 .972
Try.Rank-med 1.12335 .533 .501 -.263 .972
Difficulty.Rank-med 1.44585 -.747 .501 -.884 .972
Luck.Rank-med 1.28730 -.641 .501 -.425 .972
Medication.Rank-med 1.38358 .069 .501 -1.281 .972
Medication.Help 3.33024 -.801 .501 -.929 .972
If.Medication.Taken .64365 -.330 .501 -.510 .972
RateBefore-unmed 2.99364 -.734 .501 -.245 .972
RateAfter-unmed 1.31475 -1.456 .501 1.215 .972
Attention-unmed 2.99126 -.110 .501 l —X 00 CO .972
Trying-unmed 2.27093 -1.129 .501 -.017 .972
TaskDifficulty-unmed 3.09223 1.124 .501 COcopr .972
Luck-unmed 3.24257 -.553 .501 -.938 .972
Attention.Rank-unmed .92066 .324 .501 -.886 .972
Try.Rank-unmed 1.13599 .928 .501 .515 .972
Difficulty.Rank-unmed 1.46059 -.631 .501 -1.121 .972
Luck.Rank-unmed .79282 -.394 .501 .154 .972
Medication.Rank-unmed 1.55991 -.356 .501 -1.423 .972
Valid N (listwise)
Descriptives - Control Group
Descriptive Statistics • Control Group
N Minimum Maximum Mean
Statistic Statistic Statistic Statistic
AGE 25 6.00 13.00 9.2000
FSIQ 25 71.00 132.00 102.4800
Locus.of.Control 25 25.00 65.38 44.0844
RT.Incongruent 25 714.00 1619.00 1091.9200
RT.Matching 25 557.00 1310.00 862.9600
RT.Control 25 676.00 1509.00 1018.5600
RT.Difference 25 -197.00 270.00 73.3600
Error.Total 25 .00 6.00 1.5200
Omission.Total 25 .00 4.00 .3600
Valid N (listwise) 25
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Appendix 7.14
Descriptive Statistics - Control Group
Std. Skewness Kurtosis
Statistic Statistic Std. Error Statistic Std. Error
AGE 2.00000 .245 .464 -.955 .902
FSIQ 17.02479 -.011 .464 -.702 .902
Locus.of.Control 11.44228 .281 .464 -1.044 .902
RT.Incongruent 258.74745 .405 .464 -.800 .902
RT.Matching 188.09848 .566 .464 I COoo .902
RT.Control 234.77029 .511 .464 -.762 .902
RT.Difference 107.71602 -.248 .464 .597 .902
Error.Total 1.58430 1.293 .464 1.337 .902
Omission.Total 1.11355 3.139 .464 8.826 .902
Valid N (listwise)
Descriptive Statistics - Attribution Questionnaire Responses - Control Group
N Minimum Maximum Mean
Statistic Statistic Statistic Statistic
RateBefore 25 6.00 10.00 7.9200
RateAfter 25 5.00 10.00 8.9600
Attention 25 4.00 10.00 7.8000
Trying 25 4.00 10.00 8.3600
Task.Difficulty 25 1.00 9.00 3.2400
Luck 25 1.00 10.00 7.3600
Attention.Rank 25 1.00 3.00 1.5200
Try.Rank 25 1.00 3.00 1.7600
Difficulty.Rank 25 1.00 4.00 3.2400
Luck.Rank 25 2.00 4.00 3.4800
Valid N (listwise) 25
Descriptive Statistics - Attribution Questionnaire Responses - Control Group
Std. Skewness Kurtosis
Statistic Statistic Std. Error Statistic Std. Error
RateBefore 1.22202 .164 .464 -.805 .902
RateAfter 1.13578 -1.956 .464 5.352 .902
Attention 2.16025 -.636 .464 -1.063 .902
Trying 1.77670 -.840 .464 -.120 .902
Task.Difficulty 2.25979 .830 .464 .006 .902
Luck 2.91376 -.850 .464 -.566 .902
Attention.Rank .71414 1.043 .464 -.151 .902
Try.Rank .66332 .302 .464 -.612 .902
Difficulty.Rank .77889 -1.038 .464 1.425 .902
Luck.Rank .71414 -1.043 .464 -.151 .902
Valid N (listwise)
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7.15 Appendix: ANOVA used to examine the effect of 'Order' Variable
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Appendix 7.15
Univariate Analysis of Variance
Warnings
Post hoc tests are not performed for GROUP because there are fewer than three
groups.




GROUP 1.00 adhd-on 19
2.00 adhd-off 21
ORD.CODE .00 off-on 21
1.00 on-off 19




of Squares df Mean Square F Sig.
Corrected Model 48138.291a 3 16046.097 2.166 .109
Intercept 203807.483 1 203807.483 27.514 .000
GROUP 42281.055 1 42281.055 5.708 .022
ORD.CODE 1526.884 1 1526.884 .206 .653
GROUP * ORD.CODE 6158.438 1 6158.438 .831 .368
Error 266663.709 36 7407.325
Total 530892.000 40
Corrected Total 314802.000 39
a. R Squared = .153 (Adjusted R Squared = .082)
Profile Plots
Estimated Marginal Means of RT.Difference Score
ORD.CODE
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7.16 Appendix: Non-significant Results - Hypothesis 6 Rating Data
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Appendix 7.16
Attribution Questionnaire Responses - Rating Data
Attribution Questionnaire Responses - Experimental Group
(medicated vs unmedicated conditions)
T-Test
Paired Samples Statistics - ADHD medicated vs ADHD unmedicated - Based on
Transformed Data
Mean N Std. Deviation
Std. Error
Mean
Pair RateAfter-med 2.1559 21 .24605 .05369
1 RateAfter-unmed 2.2014 21 .16252 .03546
Pair Attention-med 2.0317 21 .44276 .09662
2 Attention-unmed 1.8327 21 .49778 .10862
Pair Try-med 2.1750 21 .19587 .04274
3 Try-unmed 2.0847 21 .34095 .07440
Pair Task.Difficulty-med .7615 21 .83739 .18273
4 Task.Difficuty-unmed .9013 21 .86540 .18885
Pair Luck-med 1.9894 21 .54918 .11984
5 Luck-unmed 1.7011 21 .77939 .17008
Paired Samples Correlations - ADHD medicated vs ADHD unmedicated - Based on
Transformed Data
N Correlation Sig.
Pair 1 RateAfter-med & RateAfter-unmed 21 .239 .297
Pair 2 Attention-med&Attention-unmed 21 .160 .489
Pair 3 Try-med&Try-unmed 21 .440 .046
Pair 4 TaskDifficulty-med&TaskDifficulty-unmed 21 .757 .000
Pair 5 Luck-med&Luck-unmed 21 .300 .186





Pair 1 RateAfter-med -
RateAfter-unmed
Pair 2 Attention-med -
Attention-unmed
Pair 3 Try-med - Try-unmed
Pair 4 TaskDifficulty-med -
TaskDifficulty-unmed
























Pair 1 RateAfter-med -
RateAfter-unmed -.1641 .0730
Pair 2 Attention-med -
Attention-unmed -.0791 .4772
Pair 3 Try-med - Try-unmed -.0506 .2312
Pair 4 TaskDifficulty-med -
TaskDifficulty-unmed
-.4101 .1306
Pair 5 Luck-med -
Luck-unmed -.0792 .6559
Paired Samples Test - ADHD medicated vs ADHD unmedicated - Based on Transformed Data
t df Sig. (2-tailed)
Pair 1 RateAfter-med -
RateAfter-unmed -.801 20 .433
Pair 2 Attention-med -
Attention-unmed 1.492 20 .151
Pair 3 Try-med - Try-unmed 1.337 20 .196
Pair 4 TaskDifficulty-med -
TaskDifficulty-unmed -1.078 20 .294
Pair 5 Luck-med -
Luck-unmed 1.637 20 .117
Attribution Questionnaire Responses - Experimental Group
(medicated condition) and Controls
T-Test
Group Statistics -ADHD medicated vs. Controls - Based on Transformed Data
GROUP N Mean Std. Deviation
Std. Error
Mean
RateAfter adhd 21 2.1559 .24605 .05369
control 25 2.1832 .14919 .02984
Attention adhd 21 2.0317 .44276 .09662
control 25 2.0095 .32009 .06402
Trying adhd 21 2.1750 .19587 .04274
control 25 2.0975 .24464 .04893
TaskDiffic adhd 21 .7615 .83739 .18273
ulty control 25 |_ -9202 .75312 .15062
Luck adhd 21 1.9894 .54918 .11984





































Independent Samples Test - ADHD medicated vs Controls - Based on Transformed Data
t-test for Equality of Means

































































Independent Samples Test - ADHD medicated vs Controls - Based on Transformed Data






assumed .05895 -.14616 .09145
Equal variances not
assumed .06143 -.15252 .09781
Attention Equal variances
assumed .11271 -.20498 .24933
Equal variances not
assumed .11590 -.21296 .25731
Trying Equal variances
assumed .06624 -.05599 .21102
Equal variances not




assumed .23460 -.63147 .31412
Equal variances not
assumed .23681 -.63702 .31966
Luck Equal variances
assumed .17068 -.22383 .46412
Equal variances not
assumed .16938 -.22130 .46159
Attribution Questionnaire Responses - Experimental Group
(Unmedicated Condition) and Controls
T-Test
Group Statistics - ADHD unmedicated vs controls - Based on Transformed Data
GROUP N Mean Std. Deviation
Std. Error
Mean
RateAfter adhd 21 2.2014 .16252 .03546
control 25 2.1832 .14919 .02984
Attention adhd 21 1.8327 .49778 .10862
control 25 2.0095 .32009 .06402
Trying adhd 21 2.0847 .34095 .07440
control 25 2.0975 .24464 .04893
TaskDiffic adhd 21 .9013 .86540 .18885
ulty control 25 .9202 .75312 .15062
Luck adhd 21 1.7011 .77939 .17008
control 25 1.8693 .59848 .11970
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Independent Samples Test - ADHD unmedicated vs Controls - Based on Transformed Data
t-test for Equality of Means




assumed .395 44 .695 .0182
Equal variances
not assumed .392 41.153 .697 .0182
Attention Equal variances
assumed -1.455 44 .153 -.1768
Equal variances
not assumed -1.403 32.990 .170 -.1768
Trying Equal variances
assumed -.148 44 .883 -.0128
Equal variances




assumed -.079 44 .937 -.0189
Equal variances
not assumed -.078 40.038 .938 -.0189
Luck Equal variances
assumed -.828 44 .412 -.1682
Equal variances
not assumed -.809 37.128 .424 -.1682
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Independent Samples Test - ADHD unmedicated vs Controls - Based on Transformed Data






assumed .04600 -.07454 .11085
Equal variances
not assumed .04635 -.07543 .11174
Attention Equal variances
assumed .12151 -.42173 .06805
Equal variances
not assumed .12608 -.43336 .07969
Trying Equal variances
assumed .08655 -.18723 .16161
Equal variances




assumed .23861 -.49983 .46195
Equal variances
not assumed .24156 -.50713 .46925
Luck Equal variances
assumed .20325 -.57786 .24139
Equal variances
not assumed .20797 -.58958 .25311
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Attribution Questionnaire Ranking - Experimental Group
Differences
T-Test
Paired Samples Statistics • ADHD medicated vs ADHD unmedicated
Mean N Std. Deviation
Std. Error
Mean
Pair Attention-med 2.3333 21 1.35401 .29547
1 Attention-unmed 2.0476 21 .92066 .20090
Pair Trying-med 2.4762 21 1.12335 .24513
2 Trying-unmed 2.0952 21 1.13599 .24789
Pair Difficulty-med 3.7619 21 1.44585 .31551
3 Difficulty-unmed 3.6667 21 1.46059 .31873
Pair Luck-med 3.5714 21 1.28730 .28091
4 Luck-unmed 3.8571 21 .79282 .17301
Pair Medication-med 2.7143 21 1.38358 .30192
5 Medication-unmed 3.3333 21 1.55991 .34040
Paired Samples Correlations - ADHD medicated vs ADHD unmedicated
N Correlation Sig.
Pair 1 Attention-med & Attention-unmed 21 .508 .019
Pair 2 Trying-med & Trying-unmed 21 .119 .606
Pair 3 Difficulty-med&Difficulty-unmed 21 .268 .240
Pair 4 Luck-med&Luck-unmed 21 .133 .566
Pair 5 Medication-med&Medication-unmed 21 .185 .421





Pair 1 Attention-med -
Attention-unmed
Pair 2 Trying-med -
Trying-unmed
Pair 3 Difficulty-med -
Difficulty-unmed
Pair 4 Luck-med - Luck-unmed
























Pair 1 Attention-med -
Attention-unmed -.2556 .8270
Pair 2 Trying-med -
Trying-unmed -.3015
1.0634
Pair 3 Difficulty-med -
Difficulty-unmed
-.7050 .8955
Pair 4 Luck-med - Luck-unmed -.9318 .3603
Pair 5 Medication-med -
Medication-unmed -1.4764 .2383
Paired Samples Test - ADHD medicated vs ADHD unmedicated
t df Sig. (2-tailed)
Pair 1 Attention-med -
Attention-unmed 1.101 20 .284
Pair 2 Trying-med -
Trying-unmed 1.164 20 .258
Pair 3 Difficulty-med -
Difficulty-unmed .248 20 .806
Pair 4 Luck-med - Luck-unmed -.923 20 .367
Pair 5 Medication-med -
Medication-unmed -1.506 20 .148
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Mean Pre- and Post- Performance Ratings for each
ParticipantGroup
Experimental Group (medicated) - Pre- and Post- Performance Ratings
N Minimum Maximum Mean Std. Deviation
Pre-Rating 21 5.00 10.00 8.8571 1.49284
Post-Rating 21 5.00 10.00 8.8571 1.79682
Valid N (listwise) 21
Experimental Group (unmedicated) - Pre- and Post- Performance Ratings
N Minimum Maximum Mean Std. Deviation
Pre-Rating 21 .00 10.00 7.1905 2.99364
Post-Rating 21 6.00 10.00 9.1429 1.31475
Valid N (listwise) 21
Control Group - Pre- and Post- Performance Ratings
N Minimum Maximum Mean Std. Deviation
Pre-Rating 25 6.00 10.00 7.9200 1.22202
Post-Rating 25 5.00 10.00 8.9600 1.13578
Valid N (listwise) 25
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7.19 Appendix: 'Thermometer' Scale used to aid Participant Rating Procedure
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